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ABSTRACT
IMPACT OF GESTATIONAL EXPOSURE TO
2,3,7,8-TETRACHLORODIBENZO-p-DIOXIN
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by
Lori S. Ahrenhoerster
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Under the Supervision of Professor Michael D. Laiosa

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a ubiquitous environmental
contaminant and the best characterized agonist of the arylhydrocarbon receptor
(AHR), a transcription factor crucial to the detoxification of numerous xenobiotics.
Studies in animals show that TCDD is immunosuppressive in adult exposures,
and epidemiological studies have found an association between TCDD exposure
and hematologic cancers. Additionally, developmental exposure to TCDD has
been shown to increase the likelihood of autoimmunity and to impair immune
response to later-life infections. The cells of the immune system are all
descended from multipotent hematopoietic stem cells (HSCs) that originate in the
fetus. This multipotency, defined as the ability to develop into several different
cell types, suggests that any impact on HSCs potentially affects all cells arising
from the original HSCs throughout the life course. During particularly sensitive
timepoints such as puberty and pregnancy, alterations initiated by early life
exposures can be triggered to cause immune disorder by shifts in hormone
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levels, stress, or other endogenous means. The effect that developmental
exposures have on later life immune disease is not completely understood, but
epidemiological statistics suggest that the rise in immunological disease is
associated with a changing environment, whether due to chemical, microbial, or
as-yet-unknown contributing factors. We investigated the effects of
developmental AHR activation on later-life immune outcomes and used a mouse
model to examine T lymphocyte development following gestational exposure to
environmentally relevant levels of TCDD. We found that developmental exposure
to TCDD significantly decreased the lymphocyte differentiation potential of HSCs,
and that this effect occurs through the fetal AHR. We also found that AHR
signaling is involved in crosstalk with the Notch1 gene—a gene which has been
linked to over half of the cases of T cell acute lymphoblastic leukemia. These
studies support the role of developmental exposure to environmental
contaminants in the development of immune disease and may lead to multiple
public health focused interventions such as development of treatments,
implementation of preventative measures, and changes in environmental policy.
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CHAPTER 1

GENERAL INTRODUCTION

2
I.

Introduction
Disease development is multi-faceted, but increasingly it has become

apparent that early life exposures—including those while still in utero—can have
profound effects on later life disease progression. This concept, the
Developmental Origins of Health and Disease (DOHaD), provides a potential
explanation for the recent increase in hematological based diseases such as
cancer, immune suppression, allergy, and autoimmunity. Common intrauterine
exposures are nutritional or hormonal, but numerous other exposures are also
known to impact the fetus’s development. For example, stress during pregnancy
has not only been linked to poor birth outcomes, which can lead to a host of
health issues, but it can also result in later-life disease in offspring. Additionally,
health can be affected by other factors such as parity or gender ratio in multiple
births. It is now known that chemical and microbial environmental exposures
during pregnancy can impact birth outcomes and fetal health. Many
environmental contaminants exert their toxicity in adults through the
arylhydrocarbon receptor (AHR). Given the increase in incidence of
hematological based diseases, we wanted to determine whether developmental
exposure to AHR agonists such as 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD)
affects hematopoietic stem cells, the process of hematopoiesis, and later life
hematological processes.
This research focuses on developmental exposure to the ubiquitous
environmental contaminant TCDD, but many additional intrauterine effects can
also impact the development of disease. While the studies described involve
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responses in the immune system following hematopoietic stem cell (HSC)
exposures, stem cells of other lineages might be similarly altered and tissues
formed from those stem cells might also contribute to disease later in life. This
effect is particularly important when applied to vulnerable populations who may
be starting life already at a disadvantage in terms of nutrition or genetics.
Understanding the contribution of developmental influences to later life health is
a Public Health priority. Not only is there a need for disease cures, but also
means of disease prevention. Furthermore, better understanding of the
connection between contaminants and diseases could inform future
environmental regulation policies.

II.

Human Development and the Life Course
In 1991, a connection was made between insufficient gestational growth

due to inadequate maternal nutrition and later-life development of coronary heart
disease (Barker, 2007, 1991). Since that discovery over two decades ago by the
physician David Barker, what is now known as the Barker hypothesis or DOHaD
has been applied to additional health effects including type 2 diabetes and
cardiovascular disease (Power et al., 2013), neurodevelopment (Monk et al.,
2013), reproductive function (Dupont et al., 2012), and immunological disease
(Dietert, 2011, 2009; Faulk and Dolinoy, 2011). While Dr. Barker originally made
his connections based on nutrition during pregnancy, other environmental
exposures, including medications and toxic chemicals, can alter physiology
during gestational development, particularly at sensitive timepoints (Fig. 1),
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resulting in later life disease (Barouki et al., 2007; Susiarjo et al., 2013). Many
immune diseases do not manifest until adulthood, making connection to
developmental exposures complicated. However, associations are being
discovered, and a recent study has connected prenatal exposure to several
persistent environmental contaminants with an increased chance of developing
asthma twenty years later—the longest range study of its type done to date (S.
Hansen et al., 2013).

Figure 1. Sensitive timepoints exist in the life course. Experiences and exposures
occurring during gestational development may impact health at later sensitive times of
development, including childhood, puberty, during the childbearing years, or later.
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A.

Epidemiology of Immune Disease

The incidence of immune disorders such as asthma (Centers for Disease
Control and Prevention, 2011), allergies (Jackson, KD et al., 2013), cancer,
diabetes (Centers for Disease Control and Prevention, 2013), and autoimmune
diseases is rising worldwide (Bach, 2002; Cooper et al., 2009), and while the
impact on adult health is substantial, children are particularly susceptible.
Leukemia, the most common childhood cancer, is responsible for 30% of
childhood cancer (Belson et al., 2007; U.S. Cancer Statistics Working Group,
2013), and it is estimated that over 25% of children in developed countries have
an immune disorder (Dietert and Zelikoff, 2010). While cure rates for childhood
leukemia are on the rise (Belson et al., 2007) and many advances have been
made in adult leukemia cure rates (Mathisen et al., 2013), most other immune
disease treatments are minimally effective at best. Known inherited factors and
single nucleotide polymorphisms have been linked to development of some
immune diseases including autoimmunity (Perl, 2012) and cancer (Du et al.,
2013; Han et al., 2013; Mosor et al., 2013; Perez-Andreu et al., 2013), and many
immune disorders tend to run in families or are common in identical twins
(Cooper et al., 2009; Rogler, 2011). However, the rise in rates is far too rapid to
be attributable to genetic susceptibility alone (Barouki et al., 2012; Schmidt,
2011), which suggests an interaction between genes and the broader
environment.
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Environmental influence can refer to chemicals or infectious agents in the
air, water, and other surroundings (Belson et al., 2007; Fazekas de St Groth,
2012; Selmi et al., 2012; Selmi, Carlo et al., 2011), or it can more specifically
refer to exposures in utero and be compounded by maternal factors such as diet,
tobacco use, or stress (Prescott and Noakes, 2007; Walker and Ho, 2012).
Given that the increase in immune disease rates correlates with the
increase in industrialization of developing countries, a further examination of the
gene-environment connection is warranted. Though the United States, through
Public Health programs such as the Clean Air Act and Clean Water Act, has
decreased emissions of environmental contaminants such as benzene, volatile
organic compounds and particulates, many others persistent in the water and
soil. Additionally, developing countries do not have as stringent environmental
protections, and in addition to chemical contaminants, a new environmental risk
has emerged. The United States and other developed countries send electronic
waste, such as discarded computers, to developing nations in Asia and Africa
where they are informally recycled by incineration, raising soil and air levels of
dioxins, flame retardants and other toxic substances to dangerous levels (Tue et
al., 2013).
A particular strength of our research model is that we use a relatively low
dose of TCDD (3µg/kg) in our developmental exposures to mimic environmental
levels. Many others who work with TCDD and immunity administer doses
between 3 and 10 times higher (10-30 µg/kg) and work with adult animals
(Benson and Shepherd, 2011; Casado et al., 2011; Dere et al., 2011; Funatake
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et al., 2008; Gasiewicz et al., 1983; Laiosa et al., 2003). We administer
developmental doses through the mother, and given that less than 0.5% of
TCDD crosses the mouse placenta (Van den Berg et al., 1994; Weber and
Birnbaum, 1985), the fetuses receive even lower amounts than the dam. The
maximum total TCDD exposure is approximately 30 ng/kg (3µg/kg x 2 doses x
0.5% = 0.03µg/kg or 30 ng/kg). As a point of human comparison, total infant
exposure to TCDD is estimated to be approximately 5.5 ng/kg in the infant’s first
six months (Gogal and Holladay, 2008). However, in more polluted areas, such
as rapidly-developing areas in Asia, the infant would have an even higher
exposure level.

B.

Developmental Biology and Stem Cells

Developmental exposures cause heightened concern about environmental
contaminants because an organism’s time in utero is particularly sensitive to
environmental insult due to the development of stem cells. Stem cells are
undifferentiated cells responsible for replenishing themselves, and differentiating
along explicit cell lineages. Because all tissues in the body are descendants of
early stem cells, any effect on early stem cells is carried with the organism
throughout its lifetime. Each organ system is formed during a particular
timeframe (Fig. 2), during which that system is most vulnerable to outside
influences. As an example, gestational week eight is when the immune system
begins to develop, though initiated from stem cells formed even earlier in
gestation.
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Figure 2. Each organ system has specific sensitive developmental windows. The
first 1000 days of life post-conception are particularly vulnerable timepoints in
development, as the foundation of all organ systems is being formed. The various
systems are illustrated above, along with the most sensitive times in their development
(Altshuler, Berg et al. 2003).

C.

Immune System Development

Hematopoiesis, the process by which immature precursor cells or HSCs
develop into mature blood and immune cells, is initiated in the yolk sac in both
mice and in humans (Fig. 3) (Orkin and Zon, 2008; Samokhvalov et al., 2007). In
mice, the anatomical location and timing of hematopoiesis proceeds in such a
way that the HSCs migrate, and the site of hematopoiesis moves to the aorta-
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gonads-mesonephros (gestational day (GD) 8-9), then the fetal liver and spleen
(GD11), and finally to the bone marrow, which remains the site of hematopoiesis
throughout adulthood (Dzierzak and Medvinsky, 1995; Orkin and Zon, 2008;
Robin, C et al., 2003). Though lengths of gestation differ, human hematopoietic
development proceeds in the same sequence as in mice. All HSCs, regardless of
location, are capable of self-renewal and differentiation in both the fetus and
adult organisms (Orkin and Zon, 2008).
HSC in aorta-gonads- HSC in liver
mesonephros (AGM) and spleen

HSC in yolk
sac

GD0.5

GD7.5

GD14.5

HSC move to postnatal anatomical
site in bone marrow
birth

Child/ adult

PPD2.5

GESTATION)
Day of vehicle or TCDD gavage

Day of HSC harvest

Figure 3. HSC location migrates throughout gestation. Timeline showing location of
hematopoiesis, including dosing regimen, for mice used in this research. For HSC
harvest, mice were administered vehicle or 3 µg/kg TCDD on GD 0.5 and 7.5. For adult
experiments, treatments continued for GD14.5 and PPD2.5.

All mammalian blood and immune cells develop from hematopoietic stem
cells and originate in the fetal liver or the bone marrow of an adult. At the top of
the hierarchy (Fig. 4) are a very rare population of multipotent long-term (LT)
HSCs, which are self-renewing and capable of differentiation into any cells of the
blood and immune system. Identifiable by the presence of several surface
markers, including CD150, along with the absence of CD48 and CD244 in the
mouse, LT HSCs comprise approximately 0.01% of whole bone marrow (Oguro
et al., 2013) and 0.10% of the fetal liver (Kim et al., 2006). Multipotent HSCs
must maintain a balance between differentiation into the many mature blood and
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immune cells, and quiescence (resting in the Go cell cycle) as self-renewing,
undifferentiated HSCs.

Figure 4. All blood cells descend from hematopoietic stem cells (HSCs). HSCs
gradually lose potency (differentiation potential) and renewal potential, becoming more
specialized. The first split is between myeloid or lymphoid lineages.

A larger but less specific subset of HSCs are identifiable by the absence
of cell surface markers for lineage-committed cells (Table 1) along with the
presence of surface markers Sca-1 and cKit (Li et al., 1995; Oguro et al., 2013;
Spangrude, G J et al., 1988). This heterogeneous population of short-term (ST)
HSCs, known as LSKs (Lin-Sca1+cKit+), are easily identifiable and commonly
employed in HSC research. LSKs are the HSC population isolated and used in
the experiments described here.
In a healthy system, each HSC will form two daughter cells—for
replacement and differentiation. In response to micro-environmental signals in
the stem cell niche, a proportion of HSCs begin differentiation along myeloid or
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lymphoid pathways (Fig. 4), and become committed to progressively more
specific lineage fate options (Luc et al., 2008). Myeloid committed precursors can
become thrombocytes (platelet-forming cells), erythrocytes (red blood cell
forming), mast cells, basophils, neutrophils, eosinophils, macrophages, or
dendritic cells. The lymphoid committed precursors can become dendritic cells or
can take one of two lymphocytic paths. Some of the undifferentiated lymphocyte
progenitors travel to the thymus, where they receive signals from a
transmembrane protein known as Notch1, resulting in maturation to T
lymphocytes (T cells). The other progenitors remain in the bone marrow, do not
receive Notch1 signals, and mature into B lymphocytes (B cells) (Deftos et al.,
2000; Zúñiga-Pflücker, 2004).
Table 1. Cell surface markers included in LSK panel
Abbreviation

Function

CD32
LY-76/Ter-1192

T cell co-receptor
Lymphocyte antigen 76
Protein tyrosine
phosphatase, receptor
type, C
Integrin αM chain
Lymphocyte antigen 6
complex, locus G

CD45R/B2202
CD11b2
LY6G/LY6C/GR-1
Sca1
cKit3
1

3

2

Stem cell antigen-1
Stem cell growth factor
receptor

Cell type it
identifies
T lymphocytes
Erythroid cells
B lymphocytes
Macrophages
Granulocytes
Hematopoietic
stem & progenitor
cells
Hematopoietic
stem & progenitor
cells

LSK refers to lineage negative, Sca1 positive, cKit positive cells
Cell types excluded in LSK
3
Cell types included in LSK
2

Both B and T cells show specificity in responding to foreign antigen but
differ in how they recognize it. Whereas B cells recognize soluble antigen, T cells
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can only recognize antigen presented by other cells—bound by the cell surface
molecule major histocompatibility complex (MHC) which forms a complex with
the T cell receptor (TCR) on the T cell. While in the thymus, pre-T cells undergo
selection to ensure that their TCRs can recognize MHC presented by self,
without reacting too strongly to self (self-tolerance). If the affinity between pre-T
cell and MHC presentation is not strong enough, the cell is destined to exit the
thymus as a naïve T cell, since these recognize only foreign proteins. If the
affinity is too strong, the pre-T cell would be self-reactive, so it is selected against
and undergoes apoptosis. But if the level of affinity is “just right,” that cell
becomes a regulatory T cell (Treg cell; Sakaguchi et al., 2008). After selection, T
cells leave the thymus competent and are able to recognize and react with
foreign antigen. When in the periphery, the TCR identifies a specific antigen,
triggering a cascade of events causing an immune response, and at this point the
T cell is activated.
Lymphocytes, developing from HSCs, can potentially be affected by
intrauterine effects resulting in later-life disease. While traditional toxicology looks
at adult exposures to potentially harmful substances, our research examines how
developmental exposures to immunotoxicants differ from adult exposures.
Because hematopoiesis maintains the functional cells of the immune system
throughout the life course (Seita and Weissman, 2010; Yamada et al., 2013),
there is a growing recognition that factors that disrupt the balance of HSC selfrenewal and lineage differentiation into immune effector cells can result in
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immune system diseases (as reviewed in Seita and Weissman, 2010) including
myeloproliferative disorders and leukemia (K. P. Singh et al., 2013).

III.

Epigenetics
One of the mechanisms proposed to explain DOHaD is epigenetic

modification (Barouki et al., 2007; North and Ellis, 2011; Susiarjo et al., 2013). An
organism’s cells each possess a copy of the same DNA, which is the blueprint for
the organism, written in genes made up of base pairs. At different developmental
timepoints and in different tissues, genes are turned “on” or “off.” But there is
evidence that dietary, chemical, or other environmental exposures can impact the
timing of the expression of genes. Epigenetics provides an explanation of tissuespecific gene regulation—especially throughout development. Common
epigenetic alterations include DNA methylation and histone modifications. DNA
methylation occurs in cytosine rich areas (CpG islands) on regions of DNA, and
results in inactivation of genes due to an inability of transcription factors to bind
(Aluru et al., 2011; Mulero-Navarro et al., 2006). Histone modifications include
acetylation, methylation, phosphorylation, ubiquitination and sumoylation of
amino acids located on the histones. They, too, result in a change in expression
of associated genes without an alteration of the DNA sequence. Increasingly,
epigenetics has come to be accepted as a means by which adult stem cells
respond to the balance of quiescence and differentiation in mature tissues
(Rinaldi and Benitah, 2014). However, environmental exposures can alter the
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epigenetic mechanisms in terms of timing or location of gene expression, and
improper methylation or histone modification in stem cells can be particularly
detrimental. Epigenetic alterations in stem cells have been linked to cancer, and
cancer stem cells have now been identified due in part to their altered ability to
self-renew and proliferate (Easwaran et al., 2014; Jordan et al., 2006). Additional
epigenetic alterations, such as methylation changes, have been shown to impact
both self-renewal and differentiation of HSCs, and alterations have been
observed in leukemic cell lines (B. Liu et al., 2013; Prasad et al., 2014).
Developmental epigenetic modifications, such as those induced by
environmental exposures, affect not only the adult, but offspring and even
grandchildren of the organism initially exposed (Anway et al., 2005; Burton and
Metcalfe, 2014). Fortunately, some of these environmentally-influenced
epigenetic modifications can be altered with diet (Carlin et al., 2013), thus
illustrating why this research is so important to public health. Dietary
interventions could be easily incorporated into maternal standards of care, thus
modulating the environmental damage.

IV.

2,3,7,8 tetrachlorodibenzo-p-dioxin
TCDD, commonly known as dioxin, has been linked to numerous adverse

human health effects, including endometriosis (Bellelis et al., 2011), neurological
and vascular issues (Pelclova et al., 2009), decreased fertility (Eskenazi et al.,
2010), endocrine disruption (Yoon et al., 2014), diabetes (Michalek and Pavuk,
2008) and cancer (Ansbaugh et al., 2013; Michalek and Pavuk, 2008; Warner et

15
al., 2011). Many of these diseases are immunological in origin, multigenerational, and potentially result from developmental exposures during
gestation or the perinatal period (Dietert, 2009; Mustafa et al., 2009, 2008).

A.

Structure and Mechanism of TCDD Toxicity

TCDD exerts its toxicity through a transcription factor known as the
arylhydrocarbon receptor (AHR). Due to its high binding affinity to AHR (Kd=10-10
– 10-9M) (Funatake et al., 2005) and because of steric hindrance (Fig. 5), TCDD
is poorly metabolized (Stevens et al., 2009), and all toxicity is mediated through
the AHR (Van den Berg et al., 1994) without confounding due to local metabolic
effects such as inflammation. Though numerous other environmental toxicants
also activate the AHR, in the laboratory setting TCDD is the most commonly
used AHR agonist.

Figure 5. The chemical structure of 2,3,7,8-tetrachlorodibenzo-p-dioxin illustrates
its resistance to metabolism. (image public domain)

B.

Human TCDD Exposures

TCDD has long been known to be toxic, and most research regarding
exposures has used animal models. However, a few cases of acute or chronic
human exposure to TCDD have occurred and these populations have been very
well studied.
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Perhaps the best-known case of human TCDD exposure was in Vietnam
War military veterans who flew aircraft from 1962-71 transporting and spraying
the herbicide Agent Orange or who worked on the ground where it was used.
Agent Orange, so named for the orange-colored barrels it was contained in, was
contaminated with TCDD. A longitudinal health study known as The Air Force
Health Study has followed veterans of this unit, Operation Ranch Hand, since
1982 (Pavuk et al., 2005). Among the health outcomes potentially linked to Agent
Orange exposure are prostate cancer, melanoma, leukemia, malignancy,
neurological disorders, and immune suppression (Institute of Medicine, 2011;
Michalek and Pavuk, 2008; Pavuk et al., 2005).
In 1976, a chemical manufacturing plant outside of Seveso, Italy
experienced a factory accident which released high levels of TCDD in the
neighboring communities (Bertazzi et al., 1998). Some of the health outcomes
potentially found following the accident include chloracne, neurologic and
reproductive effects, and changes in liver and immune function (Bertazzi et al.,
1998). Limited information exists on developmental exposures, but Seveso
cohorts showed connections between TCDD exposure and metabolic syndrome
in girls exposed pre-pubertally (Warner et al., 2013), and neonatal thyroid
function impairment 25 years after maternal exposure (Baccarelli et al., 2008).
There is disagreement on the strength of the epidemiological data
surrounding human TCDD exposures, due to great variation in the population
exposed and the concentration and length of time of exposure. Furthermore,
unlike with animal studies, human epidemiological studies are frequently
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underpowered. Finally, given the latency period associated with non-fatal
exposures, many environmental exposures are likely never associated with
health outcomes.

V.

The Arylhydrocarbon Receptor
AHR, a member of the Per-Arnt-Sim (PAS) superfamily of proteins, is an

evolutionarily-conserved, basic helix-loop-helix, ligand-activated transcription
factor responsible for xenobiotic metabolism as well as normal development and
cell cycle regulation. It promiscuously binds to multiple endogenous and
exogenous ligands. AHR can be activated by naturally occurring ligands such as
tryptophan derivatives, bilirubin, prostaglandin G (Stevens et al., 2009) and 6shogaol, an extract of ginger (Yoshida et al., 2014). AHR is activated by
numerous synthetic ligands, such as aromatic hydrocarbons, aromatic amines,
and indolecarbozoles, which are anthrogenic environmental toxicants (Aluru et
al., 2011; Beedanagari et al., 2010a, 2010b). It has been hypothesized that the
ability to bind ligands—especially those created by industry—is a secondary,
acquired function of the AHR and that its original, evolutionarily conserved
purpose has yet to be fully elucidated.

A.

Activation by Ligands

TCDD is the best-characterized ligand of the AHR, and is used in Figure 6
to illustrate the mechanism by which gene transcription follows AHR activation. In
the absence of a ligand, AHR binds to the AHR complex (which includes the
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chaperones heat shock protein 90 (HSP90), protein 23, and hepatitis B virus Xassociated protein) in the cytosol. When bound to ligand such as TCDD, AHR
dissociates from HSP90, which reveals the AHR’s nuclear localization signal,
causing a conformational change and allowing entry into the nucleus. In the
nucleus, AHR heterodimerizes with aryl hydrocarbon receptor nuclear
translocator (ARNT) via mediation by the PAS domain, and other proteins of the
complex are removed. The AHR/ARNT heterodimer recognizes DNA binding
motifs known as arylhydrocarbon response elements (AHREs—also known as
xenobiotic or dioxin response elements). AHREs are located in the promoter
region of AHR-responsive genes and binding by the AHR/ARNT heterodimer
results in differential changes in gene expression, which yield phenotypic
variation. Some of the pathways triggered by AHR activation include phase I and
II metabolism, inflammation, and cell cycling (Aluru et al., 2011; Beedanagari et
al., 2010a, 2010b; Casado et al., 2010; Cui et al., 2009; Stevens et al., 2009).
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Figure 6. TCDD induces differential gene expression through the AHR pathway.
The AHR is a bHLH, ligand-activated transcription factor primarily responsible for
xenobiotic metabolism. Agonists such as TCDD pass through the cell membrane and
bind to the AHR complex in the cytosol. Binding of the ligand reveals the AHR’s nuclear
localization signal, causing a conformational change and allowing entry into the nucleus.
In the nucleus, AHR heterodimerizes with ARNT and other proteins of the complex are
removed. The AHR/ARNT heterodimer is recognized by DNA binding motifs known as
AHREs.

One of the best-studied and most important multi-gene families of
enzymes that are located downstream of AHR is the cytochrome P450 (CYP)
family (Beedanagari et al., 2010a, 2010b; Stevens et al., 2009). The CYP family
is instrumental in metabolizing xenobiotic compounds into intermediary phase I
compounds, which are then further broken down by members of the glutathioneS transferase family (GST) and excreted (Fig. 7) (Suter et al., 2010).
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Figure 7. Phase I and Phase II enzymes are involved in detoxification. The
cytochrome P450 (CYP) enzymes often produce a more toxic intermediate which is
not readily excretable. Glutathione-S-transferases (GST) will metabolize the toxic
intermediate into a water-soluble compound which can then be excreted.

The AHR is a principle player in the detoxification pathway of many
environmental contaminants—specifically the halogenated aromatic hydrocarbons, such as polychlorinated biphenyls (PCBs), aromatic amines, polycyclic
aromatic hydro-carbons (PAHs), and other dioxins. Though our research focuses
on TCDD as the prototypical AHR agonist, the likelihood exists that many other
environmental contaminants can cause similar responses in the AHR and
downstream gene cascades. Furthermore, combinations of AHR agonists and/or
other exposures can act in an additive manner to increase likelihood of disease.
For example, mice exposed in utero to TCDD and also fed a high fat diet after
birth were twice as likely to develop mammary tumors than those exposed to
TCDD in utero but fed a regular diet (La Merrill et al., 2010).
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AHR signaling leads to three different biological pathways—adaptive, toxic
or developmental (Stevens et al., 2009). In addition to the more familiar
xenobiotic-induced detoxification, AHR is also associated with maturation, cell
proliferation, cell cycle control and homeostasis of multiple organ systems,
including the liver, vascular system, lungs, gastrointestinal and immune system
(Cui et al., 2009; Mulero-Navarro et al., 2006; Stevens et al., 2009).
Down-regulation of AHR associated genes can occur by degradation of
AHR by the ubiquitin/proteosome pathway or via negative feedback by another
PAS protein known as AHR repressor (AHRR) (Oshima et al., 2009). These
evolutionarily distinct methods prevent over-activation of AHR associated genes
(Stevens et al., 2009). However, genes can also be regulated by epigenetic
mechanisms such as hypermethylation of the promoter region, which has been
found in both mouse and human cancer cell lines and in samples from human
acute lymphoblastic leukemia (ALL) tumors (Beedanagari et al., 2010a; MuleroNavarro et al., 2006).
Prenatal exposure to TCDD even prior to implantation has an effect on the
methylation of some imprinted fetal genes, thus impacting their expression (Wu
et al., 2004). However, this may be dose-dependent and only observable at
comparatively high doses (ie: 10 ng/kg/day = 0.01µg/kg/day but not 2ng/kg/day)
(Somm et al., 2013). Although not directly affecting HSCs, AHR activation does
epigenetically modify immune cells that are derived from HSCs. Specifically, it
has been suggested that epigenetic regulation is responsible for a decrease in
the number of CD4+ T lymphocytes and an increase in the number of Treg cells in
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adult animals following developmental AHR activation and challenge with
influenza virus (Boule et al., 2014).

B.

AHR and the Immune System

AHR is essential for immune development, including regulation of
hematopoiesis (Casado et al., 2010), induction of auto-immune fighting Treg cells
(K. P. Singh et al., 2011; Wu et al., 2011), and maintenance of HSCs in the
quiescent or resting stage (Oguro et al., 2013). In AHR knock-out mice (AHR-/-),
multiple immunological defects are found, including abnormal HSCs with
decreased self-renewal potential (K. P. Singh et al., 2011), altered spleen and
thymus lymphocyte counts (Casado et al., 2010), enlarged spleen in females
(Esser, 2009), and perinatal extramedullary hematopoiesis in the liver (Harrill et
al., 2013). Additionally, myeloproliferative hematopoietic diseases are more
common in mice lacking AHR (K. P. Singh et al., 2013).
Though AHR is necessary for regular development, over-activation is as
detrimental as lack of AHR. Many environmental contaminants that are
byproducts of combustion exert their toxicity through the AHR. The potent AHR
agonist TCDD has been linked to numerous poor health outcomes in adult
animals, including gastrointestinal hemorrhage, liver toxicity, thymic atrophy, and
death (Sorg, 2013). AHR activation also results in direct immunosuppression
(Esser, 2009; Hao and Whitelaw, 2013), reduces B cell maturation, and
increases the severity of some autoimmune diseases (Hao and Whitelaw, 2013).
Laboratory research has shown suppression of humoral and cellular immune
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response, increased susceptibility to infection, and thymic involution all following
TCDD exposure (Stevens et al., 2009). Since the thymus is the site of T cell
development, the direct effects of thymic involution are thymocyte loss and
premature thymic emigration of T cells. Therefore alterations in the AHR and
downstream metabolic target genes of AHR have been implicated as
susceptibility factors for numerous cancers (Mulero-Navarro et al., 2006) and
autoimmunity (Stevens et al., 2009).
Despite the negative health effects connected to adult AHR activation, one
interesting inconsistency exists. Adult humans and animal models exposed to
AHR agonists have shown improvement in numerous autoimmune diseases,
including psoriasis (Di Meglio et al., 2014), Crohn’s disease (Benson and
Shepherd, 2011), colitis (Furumatsu et al., 2011), Type 1 diabetes (Kerkvliet et
al., 2009), uveoretinitis (Zhang et al., 2010), and a murine model of multiple
sclerosis (Hamza and Abdullah, 2013). The mechanism by which AHR activation
in adult murine models improves autoimmune disease symptoms involves Treg
cells (Benson and Shepherd, 2011; Funatake et al., 2008; Gandhi et al., 2010;
Marshall and Kerkvliet, 2010; Mezrich et al., 2010; Zhang et al., 2010).
Conversely, exposure to AHR agonists during fetal development has shown that
prenatal AHR activation by TCDD increases immune disorder (Gogal and
Holladay, 2008; Holladay et al., 2011; Mustafa et al., 2009), specifically leading
to a loss of tolerance in later life.
Given the paradox in disease outcomes related to the AHR and the
potential for benefits following AHR activation, a recent focus of research
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involves non-toxic dietary AHR agonists such as those derived from Lactobacillus
bulgaricus (Takamura et al., 2011), resveratrol (Rimmelé et al., 2014) and
multiple tryptophan derivatives (Bock, 2013). These endogenous ligands differ
most notably from TCDD in their transient activation of the AHR. These and other
non-toxic AHR agonists have shown promise in combatting both autoimmune
and inflammatory diseases (Busbee et al., 2013).
In addition to an increase in autoimmunity, developmental AHR activation
has been linked to impairment of multiple cell-mediated immune functions
(Holladay and Smialowicz, 2000) including response to influenza infection (Boule
et al., 2014; B A Vorderstrasse et al., 2004). In mice, while exposure to TCDD
throughout gestation and lactation does not initially affect T cell ratios, when the
same mice were infected with influenza, the frequency of CD4+ Treg cells
increased and activated CD4+ T cells decreased (Boule et al., 2014). Similarly, in
humans, maternal AHR activation has been linked to immunosuppressive
response to measles vaccine in offspring three years later (Hochstenbach et al.,
2012). Given the drop in vaccination rates in developed countries for non-medical
reasons, adding a similar drop in vaccine effectiveness due to environmental
exposures could allow a return of many nearly eradicated diseases.
Furthermore, while adult AHR activation results in transient immune
effects, developmental activation has been linked to more persistent functional
effects (Hogaboam et al., 2007). This emphasizes the importance of timing of
AHR activation—the specifics of which have yet to be fully elucidated.
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AHR is just one of the signaling pathways involved in immune system
development and maturation. Pathway crosstalk is common, and the AHR is
known to crosstalk with pathways including protein kinases (Esser et al., 2009),
which are important for immune system regulation and function. Furthermore,
dysregulation in protein kinases has been linked to disease development,
including leukemia and myeloproliferative neoplasms (Gery and Koeffler, 2013).
Discovery of additional pathway crosstalk with AHR could help explain the recent
increase in immune disorders.

VI.

Notch
Notch is necessary for direct cell-to-cell contact involved in regulation of

cell development in the embryo and during adulthood. Notch proteins are highly
conserved receptors found on the cell surface (Fig. 8) (Alam et al., 2010;
Borggrefe and Oswald, 2009; Osborne and Minter, 2007; Schmitt and ZúñigaPflücker, 2002). The four Notch proteins (Notch 1, 2, 3, & 4) have been found in
all animal species to date (Lai, 2004). The Notch ligands in vertebrates are made
up of members of the Jagged (Jagged 1 & 2) and Delta-like (DL1, DL3, DL4)
families. Both the receptors and the ligands are single-pass transmembrane
proteins and each possess an extracellular epidermal growth factor (EGF)
repeating motif necessary for direct contact mediation between the two
(Ferrando, 2009; Lai, 2004).
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A.

The Notch Signaling Pathway

It has been suggested that AHR-mediated environmental signals can
contribute to over-stimulation of Notch, resulting in tumors, T cell acute
lymphoblastic leukemia lymphoma (T-ALL), and other cancers (Alam et al.,
2010).
The thymus is rich in Delta-like Notch ligands (Zúñiga-Pflücker, 2004)
which play a role in hematopoietic cell fate decisions. Ligands such as DL1
interact with the extracellular portion of Notch. In addition to the extracellular,
EGF-rich portion, Notch also has an intracellular portion (ICN). The intercellular
domain is responsible for binding to transcriptional repressor CBF1-suppressor of
hairless-Lag1 (or CSL). Even before encountering ligand, Notch receptors
undergo activation in preparation for signaling. Notch receptors are housed in the
endoplasmic reticulum in an inactive form. In the Golgi complex, the receptor is
constitutively cleaved by a furin-like protease, forming a non-covalently bound
heterodimer composed of the extracellular and intercellular portions, and
reassembled into a cell surface receptor (Lai, 2004). The extracellular portion is
then glycosylated (Osborne and Minter, 2007).
When a Notch receptor on a lymphocyte progenitor physically interacts
with a Notch ligand such as a Delta-type ligand present on a stromal cell, EGF
repeats on the ligand interact with the Notch receptor and trigger the second
cleavage—which results in release of the extracellular portion of Notch. The third
step involves cleaving of ICN by gamma secretase (Schmitt and Zúñiga-Pflücker,
2002), which allows the ICN to travel to the nucleus, where it associates with a
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constitutive CSL transcription factor (CBF1-Su(H)-LAG-1 in humans; RBP-J in
the mouse), as a co-activator which drives T cell commitment (Borggrefe and
Oswald, 2009; Lai, 2004; Osborne and Minter, 2007; Pajerowski et al., 2009).
CSL is associated with co-repressors when Notch is not present, which prevent
Notch target gene transcription (Lai, 2004) and drive B cell commitment
(Osborne and Minter, 2007; Zúñiga-Pflücker, 2004). ICN, upon association with
the co-activators, recruits transcriptional co-activators from the mastermind-like
(MAML) family, which allow the expression of Notch target genes (Pajerowski et
al., 2009). MAML1 may also serve to mediate early T cell development, as it has
been shown in vitro to increase phosphorylation and subsequent Notch receptor
degradation when combined with CSL (Osborne and Minter, 2007).
Several Notch target genes have been identified to date. These include
the highly evolutionarily conserved hairy/enhancer of split (HES) family—basic
helix-loop-helix (bHLH) proteins, which are essential for T cell development and
signaling, and a related family—HES with YRPW motif (HEY—also known as
HERP). Both HES and HEY members can be activated by constitutive Notch1
and act as transcriptional repressors. HES1 and HES5 over-expression also
inhibits B cell development. In addition to T cell development and signaling,
Notch target genes have been associated with T cell activation, proliferation,
cytokine production and protection from apoptosis (Osborne and Minter, 2007).
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Figure 8. Notch activation by ligands induces differential gene expression driving
T cell commitment. The Notch receptors are composed of an extracellular portion with
EGF repeats, and an intercellular portion. When the EGF repeats on a Notch ligand
(Delta or Jagged families) contact the extracellular portion of a Notch receptor, gamma
secretase is responsible for lysis of the intercellular (NICD) portion of Notch. NICD then
moves into the nucleus of the cell where it interacts with a CSL (RBP-J in the mouse) coactivator to drive expression of genes, including those involved in T cell commitment.

While Notch is also involved in development of CD4+ and CD8+ single
positive (SP) T cells from CD4+CD8+ double positive (DP) precursor thymocytes,
the definitive link between Notch signaling and T cell development concerns the
T cell vs. B cell fate decision at the progenitor step of development.
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B.

In vitro Culture of T cells, Using Notch

Early lymphocyte differentiation research most often focused on B cells
because they were relatively easy to grow in the lab from HSCs in a co-culture
system with murine bone marrow stromal cells. Since B cells differentiate in the
bone marrow, these stromal cells provided all the signaling needed for
maturation from HSC to effector B cells. However, T cells differentiate in the
thymus, and until 2002, the only way to model HSC differentiation into T cells
was by using the much more involved fetal thymic organ culture (FTOC). While it
was known that Notch played a necessary role in T cell commitment, the
component of the Notch pathway that could be isolated from the thymus and
used to help grow T cells in vitro was still unknown.
Schmitt and Zúñiga-Pflücker were the first to successfully engineer a cell
line that could support the commitment, development, and growth of T cells in the
lab (Schmitt and Zúñiga-Pflücker, 2002; Zúñiga-Pflücker, 2004). They began with
the bone marrow stromal cell line derived from OP/OP mice (and therefore
named OP9) which had previously been used to support the growth of B cells
and NK cells from both bone-marrow derived HSCs and also from embryonic
stem cells (ESCs). Both OP9 cells and thymic stromal cells were found to
transcribe Jagged-1 and Jagged-2, but only the thymus transcribed Delta-like-1
and Delta-like-4.
Schmitt and Zúñiga-Pflücker developed a line of OP9 stromal cells which
were retrovirally transduced to express the Notch ligand Delta-like-1. The
resulting cell line was named OP9-DL1. The OP9-DL1 stromal cell line and an
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OP9-GFP non-Delta-like-1 expressing control stromal line were used to test the
growth of hematopoietic progenitor cells (HPCs). LSKs harvested from fetal livers
were co-cultured on both OP9 cell lines in the presence of interleukin-7 (IL-7) and
Fma-related tyrosine kinase 3 (FLT3) ligands (Schmitt and Zúñiga-Pflücker,
2002; Zúñiga-Pflücker, 2004). Development was followed via flow cytometry
analysis for up to 17 days (Fig. 9).

A.
FLT3-L
IL-7
12-14
days
LSK cell
Lymphocyte

B.

OP9 stromal cell
Figure 9. The OP9-LSK co-culture system includes bone marrow stromal cells and
HSCs. A) LSK cells isolated from GD14.5 fetal livers are grown in co-culture with OP9
bone marrow stromal cells in the presence of FLT3-L and IL-7 for 12 (T cell) or 14 (B
cell) days. B) Mature lymphocytes grown in co-culture with OP9 bone marrow stromal
cells. Cells were harvested from co-culture and analyzed by flow cytometry for B or T
lineage development.

The control OP9-GFP cells resulted in mature B cells and natural killer
(NK) cells starting on day 4 and continuing through day 12, and did not produce
any T cells. However, the LSKs cultured on OP9-DL1 cells gave rise to DP
immature T cells starting on day 7 and developing through day 12 (Schmitt and
Zúñiga-Pflücker, 2002). The pattern of development follows that of HSCs in
FTOC, including maturation from double negative (DN; CD4-CD8-) to double
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positive (DP; CD4+CD8+) and single positive (SP; CD4+ or CD8+) T cells, as
well as generation of both ɣδ-TCR and αβ-TCR T cells. In addition, the T cells
grown were found to be functionally mature, as they produced IFNɣ when
stimulated by CD3 and TCR (Schmitt and Zúñiga-Pflücker, 2002). Finally, the
HSCs were obtained from mouse fetal livers, which are considerably larger and
easier to obtain than the fetal thymus. Chapters three and four of this dissertation
rely on the OP9 co-culture system to measure HSC differentiation potential.

C.

Notch in T-ALL

Notch mutations have been correlated with the occurrence of T cell acute
lymphoblastic leukemia (T-ALL) (Ferrando, 2009; Gordon et al., 2009; Kumar et
al., 2014; N. Liu et al., 2013; Paryan et al., 2013; Tosello and Ferrando, 2013;
Weng et al., 2004). Over half of the diagnosed cases of T-ALL have activating
Notch1 mutations. Overexpression of the intracellular portion of Notch1 (ICN)
drives CD8+ commitment at the expense of CD4+ commitment and transgenic
mice that overexpress ICN are prone to T cell thymic tumors (Fowlkes and
Robey, 2002). We use thymocyte specific lck-proximal promoter over-expressing
ICN transgenic mice in the experiments described in chapter five.

VII.

Study Rationale
Given that the AHR has been linked to immunological disease in adult

models and it is recognized that developmental exposures are frequently more
detrimental due to impact on stem cells, we hypothesized that developmental
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exposure to AHR agonists such as TCDD alter HSCs in a manner that negatively
impacts later-life immunity.
An organism’s time in utero is developmentally unique, as it transforms
from a fertilized egg into a multi-cellular organism. The initial multi-potent stem
cells, able to differentiate into all types of cells, gradually become committed to
particular lineages, such as the hematopoietic lineage. Because the directions for
development of the mature immune system is directed by DNA in the HSCs, any
resulting impact on HSCs during gestation—such as the failure to differentiate
correctly—can reprogram the genetic code, leading to immunodeficiencies later
in life. The immune system formed from imperfect HSCs may exhibit
immunosuppression (an insufficient ability to fight infection), may not correctly
develop self-tolerance (resulting in autoimmunity), or may not balance
replenishment and differentiation correctly (resulting in cancer). The overall goal
of this research was to determine what role developmental exposure to AHR
agonists such as TCDD has on later-life immunity.
The effect that developmental exposure to TCDD has on the ability of
HSCs to differentiate into lymphocytes was determined using a novel limiting
dilution analysis assay. HSCs were isolated on GD14.5 from fetal livers of
C57BL/6 mice exposed to either vehicle control or 3µg/kg TCDD throughout
gestation. HSCs were co-cultured with OP9 bone marrow stromal cells and the
ability to differentiate into B or T lymphocytes was measured using Extreme
Limiting Dilution Analysis (ELDA) for stem cell research (Hu and Smyth, 2009).
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Developmental TCDD exposure was found to decrease by two and a half fold the
ability of HSCs to become mature B cells or thymocytes.
Given that TCDD is the most potent AHR agonist known, we hypothesized
that developmental TCDD exposure induces differentiation effects by fetal AHR
activation. The role that fetal AHR plays in HSC development after gestational
exposure to TCDD was determined by repeating the limiting dilution assay using
HSCs from transgenic mice lacking an AHR. We found that AHR in the fetus is
responsible for the effects caused by developmental TCDD exposure, which
results in a decrease in the potential of HSCs to differentiate into mature
lymphocytes. Mice lacking an AHR do not experience the TCDD-induced
decreased thymocyte differentiation effect.
The role that developmental exposure to TCDD plays in T cell
development in adults was determined using transgenic mice that overexpress
Notch1, which is implicated in over half the cases of T-ALL. Notch has been
associated with the maintenance of undifferentiated HSCs (Zhou et al., 2010)
and is downregulated as HSCs differentiate (Duncan et al., 2005). We exposed
Notch transgenic mice to TCDD throughout gestation and lactation, then followed
the mice through adulthood, tracking blood cell phenotype weekly. We found that
the crosstalk between AHR, as developmentally activated by TCDD, and later
Notch1 signaling does not act in an additive manner, but rather in what appears
to be a competitive manner, resulting in more typical T cell ratios and better
health outcomes in the transgenic mice developmentally exposed to TCDD.
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These studies contribute significantly to our knowledge of the AHR during
development, the effect of environmental insult on genetically-susceptible
populations, DOHaD specific to the immune system, and the mechanism by
which these effects occur. This research provides an important contribution to
public health because of the need to elucidate reasons for increasing disease
rates in order to drive policy and to develop preventative health strategies
(Barouki et al., 2012). Prevention plays a critical role because unlike
polymorphisms such as BRCA1, epigenetic alterations are reversible with dietary
interventions (Carlin et al., 2013).
While research findings support the impact of dioxin-like chemicals as
factors increasing immune disorders, and efforts are being made to decrease
environmental contaminants, the genetic component is equally important to
complete understanding of this health crisis. Given that the increase in immune
disorders is likely the result of a combination of genetic and environmental
causes (Faulk and Dolinoy, 2011), determining at which stage(s) developmental
AHR activation causes immune dysfunction would allow clinical intervention at an
early time point. The ability to test stem cells for genetic or epigenetic alterations
could identify susceptible populations and focus potential preventative efforts at
an early stage in particularly vulnerable people and to counsel patients at risk on
avoiding additional risk factors. Furthermore, elucidating the genetic aspect of
susceptibility provides a therapeutic focus (Quintana, 2012).
Finally, an underdeveloped immune system can not only increase
development of immune-related diseases, but also result in an immune system
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less likely to respond favorably to immunization (Hogaboam, Moore et al. 2008).
Though public health practice aims for 100% immunization, in order for effective
population immunity, vaccination rates need only meet the herd immunity
threshold, which varies depending on the vaccine and population (Fine et al.,
2011). However, even if the threshold is reached, if not all vaccinated are
achieving full immunity from vaccines due to deficient immune systems, a public
health crisis could emerge.
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CHAPTER 2

MATERIALS AND METHODS
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Solutions and Buffers
MEM: Minimum Essential Medium alpha (α-MEM; Life Technologies,
Carlsbad, CA); 1 packet, combined with 2.2 g NaHCO3, topped off with 1 L
ddH2O, stirred for 10 minutes and filter sterilized using a 0.2µm filter (aPES
membrane), then stored at 4oC in the dark.
OP9 media: MEM supplemented with 20% FBS (lot tested for supporting
OP9 co-cultures; Life Technologies) and 0.05mg/mL gentamycin (Life
Technologies), filter sterilized and stored at 4oC in the dark.
DMEM complete: Dulbecco’s Modified Eagle Medium (Mediatech,
Manassas, VA); supplemented with 10% fetal bovine serum (FBS; Invitrogen,
Grand Island, NY), 1% L-glutamine (Invitrogen), 1% 1 M HEPES (Invitrogen),
0.01% 0.5 M 2-Mercaptoethanol (EMD, Gibbstown, NJ), and 0.001 mg/mL
gentamycin (Life Technologies), filter sterilized and stored at 4oC in the dark.
Serum-free DMEM: Dulbecco’s Modified Eagle Medium (Mediatech);
supplemented with 1% L-glutamine (Invitrogen), 1% 1 M HEPES (Invitrogen),
0.01% 0.5 M 2-Mercaptoethanol (EMD), and 0.001 mg/mL gentamycin (Life
Technologies), filter sterilized and stored at 4oC in the dark.
FACs buffer: Fluorescence activated cell sorting buffer; consisting of
Hank’s buffered saline solution (HBSS; Corning CellGro, Herndon, VA),
supplemented with 0.5% FBS (Invitrogen) and 0.1% sodium azide (J.T.
Baker/Avantor, Center Valley, PA), then stored at 4oC in the dark.
RBC lysis buffer concentrate: Red blood cell lysis buffer, consisting of
8.02 g (155 mM) NH4Cl (ammonium chloride) + 0.84 g (12 mM) NaHCO3 (sodium
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bicarbonate) + 0.37 g (0.1 mM) EDTA (10X concentration), then filled to 100ml
with Millipore water. Diluted 1:10 before use.

Experimental Animals
All animal procedures were conducted according to NIH’s Guide for the
Care and Use of Laboratory Animals (National Research Council, 2011) and with
the approval of the Institutional Animal Care and Use Committee (IACUC) at the
University of Wisconsin-Milwaukee. C57BL/6J (B6) and B6.129-Ahrtm1Bra/J (AHR)
mice used were obtained directly from the Jackson Laboratory (Bar Harbor, ME),
or were offspring from original Jackson mice. Due to reproductive deficiency of
AHR-/- females, this strain was maintained by either HZ x HZ (AHR+/- x AHR+/-)
or KO (AHR-/-) male x WT (C57BL/6J; AHR+/+) female pairings. C57BL/6Tg(LckNotch1)9E mice, hereafter referred to as Notch1ICN-TG mice, were offspring
of original pups that were a generous gift from B.J. Fowlkes, PhD, at the National
Institute of Allergy and Infectious Disease (NIAID), Bethesda, MD. These mice
were maintained as homozygous stock prior to breeding to C57BL/6 to generate
heterozygous Notch1ICN-TG used for all experimental procedures.
After overnight pairings, the presence of a vaginal mucus plug was used
as evidence of mating and designated “gestational day (GD) 0.5.” For breeding
resulting in live birth offspring, mice were placed together for 4-7 days and
checked for presence of vaginal plug each morning. However, for time-sensitive
breeding, animals were placed together between 3:00 pm and 5:00 pm and
presence of vaginal plug was determined between 7:00 am and 9:00 am the next
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morning to ensure that fetuses were as close to similar developmental age as
possible. This was a change in protocol from week-long breeding periods as it
was determined that fetuses from the same day vaginal plug observations still
appeared varied in size and developmental stage.
For breeding resulting in live birth offspring after gestational exposure to
TCDD, all multiparous mothers were used. This change in protocol came about
due to a high percentage of neonatal deaths, possibly due to either a lack of
mothering experience or a failure of mammary gland differentiation after
exposure to TCDD (Lew et al., 2009; Beth A Vorderstrasse et al., 2004).
All mice were housed in micro-isolator cages in a specified pathogen-free
facility at the University of Wisconsin-Milwaukee, provided food and water ad
libitum, and maintained on a 12:12-h light cycle.

Genotyping of Transgenic Mouse Strains
Tissue samples were collected as ear punches from adult mice and tail
samples from fetal mice. Ear tissues were digested with rotation at 55oC
overnight in 190µl DirectPCR Lysis Reagent (ViaGen Biotech, Los Angeles, CA)
plus 10 µl Proteinase K (ViaGen Biotech). Fetal tail tissues were digested in
160µl Direct PCR lysis buffer plus 40 µl Proteinase K for 20 minutes with
intermittent vortexing in a locking-cap 1500µl microcentrifuge tube (Eppendorf,
USA). Proteinase K in samples tubes was then inactivated for one hour at 85oC
(ear) or a 1:5 diluted sample for 20 minutes at 95oC (fetal tail). Primers (Table 2)
were thawed over ice. Reaction samples were mixed, each containing 12.5µl
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MyTaq, 0.5µl each primer, 9.5µl DNAse free water, and 2 µl of genomic DNA.
Samples were run in thermocycler according to specifications listed in Table 3.

Table 2. qPCR SybrGreen primers used
Gene
name

Direction

Sequence

forward

CAGTGGGAATAAGGCAAGAGTGA

reverse

AGGGAGATGAAGTATGTGTATGTA

forward

CAACAGGGAGGAAACACAACAG

reverse

GTTTGGATGCCTTCCTCTAGGT

forward

TCATGAGACTGCCAACCACAG

reverse

CATGACCACCACCACCACCAA

forward

TTACGTCCATCGTGGACAGC

reverse

TGGGCTGGGTGTTAGTCTTA

AHR

HgH

SrY

Myog

Table 3. Thermocycler specifications
Gene
name

Stage

Temp

Time

1

95oC

3 min.

95oC

5 sec.

58oC

5 sec.

72oC

10 sec.

72oC

5 min.

4o C

-

2
AHR

3

Note

Repeat
stage 2 for
30 cycles

Hold
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1

94oC

5 min.

2

4o C

30 sec.

63oC

1 min.

72oC

1 min.

72oC

7 min.

HgH
3

o

1

Sry
&
Myog

2

3

Hold

4C

-

94oC

3 min.

94oC

5 sec.

57oC

5 sec.

72oC

15 sec.

72oC

1 min.

o

4C

Repeat
stage 2 for
35 cycles

Repeat
stage 2 for
30 cycles

Hold
-

PCR samples were run on a 2.2% Lonza FlashGel single tier DNA
cassette (Lonza, Allendale, NJ) at 225 V for 15-20 minutes, while MovieMaker
(Microsoft, Redmond, WA) ran continuously, recording band migration.

TCDD Preparation and Treatment Protocol
TCDD (Cambridge Isotopes, Andover, MA) was diluted in 1,4-dioxane
(Sigma-Aldrich, St. Louis, MO) to a working stock concentration of 0.2 mg/ml.
Appropriate volume of TCDD in 1,4-dioxane was subsequently transferred to a
sterile 15 ml conical tube and the liquid was evaporated in a chemical fume hood.
The remaining TCDD residue was then suspended in olive oil (Filippo Berio,
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Hackensack, NJ) to a concentration of 0.3µg/ml, 1.0µg/ml or 3.0µg/ml and was
mixed by rotation overnight at room temperature. For dosing of vehicle control
mice, olive oil was added to a tube from which an equal volume of 1,4-dioxane
had been evaporated.
For experiments where LSKs were isolated from GD 14.5 fetal livers,
pregnant mice in the treatment group were exposed to either 3µg TCDD/kg body
weight by oral gavage on gestational days 0.5 and 7.5, or olive oil vehicle control
(0.1ml per 10g) on the same days. Doses were given 7 days apart to insure a
relatively constant level of TCDD throughout because the half-life of TCDD in a
C57BL/6 mouse is approximately one week (Gasiewicz et al., 1983; Hogaboam
et al., 2007; Miniero et al., 2001; Weber and Birnbaum, 1985).
For experiments where developmentally-exposed mice were allowed to
grow to adulthood, pregnant mice in the treatment group were given 3µg
TCDD/kg body weight by oral gavage on GDs 0.5, 7.5, 14.5, and post-partum
day (PPD) 2.5, while the control mice received an equivalent volume of olive oil
(0.1ml per 10g) on the same days. This dosing regimen included not only in utero
exposure, but also lactational exposure, mimicking the pattern of exposure in the
environment. Such methodology was chosen to accurately represent
environmental exposure as TCDD has been found to be more detrimental when
maintained throughout development (Hogaboam et al., 2007).
For some experiments rather than a developmental exposure, four week
old naïve mice were exposed to a single dose of 10µg or 30µg TCDD/kg body
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weight or an equal volume of vehicle control (0.1 ml per 10g) by oral gavage and
tissues were analyzed 10 days after exposure.

Antibodies Used for HSC/HPC and Lymphocyte Staining
Primary fluorochrome-conjugated monoclonal antibodies were used in
flow cytometry analysis and cell sorting (Table 4) on a BD FACSAria III, DIVA
version 6.1.3.
Table 4. Monoclonal antibodies, clones and fluorochromes used in
fluorescence activated cell sorting and flow cytometry analysis
Antibody
Clone
Fluorochrome*
B220
RA3-6B2
PE
CD3
145-2C11
biotin
CD3
145-2C11
PE-CF594
CD4
RM4-5
APC-H7
CD4
RM4-5
PECy5
CD4
RM4-5
PE
CD5
53-7.3
biotin
CD11b
M1/70
biotin
CD11b
M1/70
Alexa488
CD19
1D3
FITC
CD25
7D4
biotin
CD44
IM7
PECy5
CD45
30-F11
PE
CD45R/B220
RA3-6B2
biotin
CD8α
53-6.7
PE-Cy7
CD8α
5H10
Alexa647
1
cKit
2B8
Alexa647
GR-1
RB6-8C5
APC-Cy7
LY-76
TER119
biotin
LY6G/LY6C/GR-a RB6-8C5
biotin
Sca-1
E13-161.7
PE
Streptavidin
FITC
Streptavidin
PE-TR
*FITC=fluorescein isothiocyanate; PE=phycoerythrin; Cy=cyanine; APC=allophycocyanin;
TR=Texas Red
1
Purchased from Life Technologies
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HSC/HPC populations were identified by the absence of lineage markers
(CD3, LY-76, CD45R/B220, CD11b and LY6G/LY6C/GR-a1) and presence of
two stem cell markers (Sca-1 and cKit).
Immature thymocytes and B cells resulting from OP9 co-culturing were
identified based on expression of CD8α, CD4, CD25, CD44, B220 and CD19.
Weekly blood and tissue cells were identified based on expression of
CD19, CD11b, CD45, CD3, CD4, CD8 and GR-1. Tumor cells were identified by
the presence of CD5 after gating on CD3+ populations and within CD4+ or CD8+
subsets.
For thymocyte and splenocyte cellular analysis, living cells were first
identified by staining with 10µl of the vital dye Sytox Blue (Life Technologies),
1mM, diluted 1:80, to label nuclei from dead or dying cells with permeable
membranes. Sytox Blue negative cells were then identified by the presence of
CD4 and/or CD8.
For adult high-dose exposures, total cellularity was determined by dilution
in viable cell determining trypan blue and manual counting using a
hemocytometer (Fisher Scientific, Pittsburg, PA). Cells were then identified by
the presence of CD4, CD8, CD44, CD3 and CD25.
For cell-cycle experiments, co-cultures were incubated in the presence of
10 mM 5-bromo-2’-deoxyuridine (BrdU) for one hour prior to harvest. Cells were
then stained with appropriate surface markers followed by fixation and
permeabilization using the BD FITC BrdU flow cytometry kit according to the
manufacturer’s instructions (BD Biosciences). Thymocyte precursors were
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identified by the presence of both CD4 and CD8α surface markers. B cell
precursors were identified by presence of both B220 and CD19 surface markers.
All antibodies were used at titrated concentrations and were purchased
from BD Biosciences unless otherwise noted.

Fetal Liver HSC Isolation and Cell Sorting
Pregnant C57BL/6J or AHR+/- mice were euthanized by CO2 asphyxiation
according to the AVMA Guidelines on Euthanasia (AVMA, 2013) on GD 14.5.
Dissections and tissue harvest were carried out within a 2 hour window (7:00 am9:00am CST) each day to minimize time-of-day fluctuations in HSC numbers (K.
P. Singh et al., 2011). Fetuses were removed to culture dishes containing cold
DMEM complete media.
For all HSC experiments, fetal livers were removed from individual
fetuses, mechanically dispersed in DMEM complete, and passed through sterile
Nitex nylon mesh (80µm; Wildco, Yulee, FL) to form single-cell suspensions.
Mature fetal liver cells were eliminated by CD24-mediated (clone J11d.2)
complement-dependent lysis with low tox Rabbit Complement (Cedarlane,
Burlington, NC) at 37oC for 30 minutes with gentle agitation. After centrifugation
at 300 g for 5 minutes, pellet was then re-suspended in serum-free DMEM and
depleted of dead cells by centrifugation over Lympholyte Mammal (Cedarlane) at
800g for 20 minutes (Carlyle and Zuniga-Pflucker, 1998). Remaining cells were
harvested from the buffy layer, washed three times in DMEM complete, and
sorted.
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Sorting of hematopoietic stem cells was first based on the absence of
mature lineage markers in a cocktail of antibodies including CD3, LY-76, B220,
CD11b and GR-1, as described above. Lineage negative (Lin-) cells were further
identified by the presence of Sca-1 and cKit, also described above.
Cells were sorted on a BD FACSAria III, DIVA version 6.1.3, equipped
with four laser (violet 407 nM, blue 488 nM, yellow/green 561 nM and red 633
nM), four way sorting capacity and an automated cell deposition unit capable of
sorting a single cell into an individual well on a 96 well tissue culture plate. Just
prior to cell sorting, 10µl of the vital dye Sytox Blue (Life Technologies), 1mM,
diluted 1:80, was added to label nuclei from dead or dying cells with permeable
membranes. Sytox Blue negative cells were electronically gated on the 407 violet
B detector. Subsequently, doublets were excluded using FSC Height X Width
and SSC Height x Width discrimination. Lin- cells were detected on the Blue B
detector with a 502LP mirror and 530/30 filter. Sca-1+ cells were detected on the
yellow-green D detector with a 582/15 filter set. c-Kit+ cells were detected on the
Red B detector with a 660/20 filter set. Lineage-Sca-1+cKit+ (LSK) cells were
directly sorted into individual wells on a Costar tissue culture treated 96 well plate
(Corning, Corning, NY) at concentrations ranging from 1-30 cells per well, or
sorted into a single tube and then divided into aliquots of 4000 cells per well in a
24 well plate (Corning). Both 96- and 24-well plates were pre-seeded with
mitomycin C treated OP9-GFP or OP9-DL1 adherent bone marrow stromal cells
at 75-85% confluency (described below).
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Blood and Tissue Harvest and Analysis
For analysis of immune cell ratios, mice were weighed and blood was
harvested weekly, beginning at 5 weeks of age and ending at 12 weeks of age.
For maxillary blood collection, mice were restrained by hand, then the right cheek
was nicked with a 5 mm Goldenrod animal lancet (Medipoint, Inc., Mineola, NY).
Approximately 100µL of blood was collected from the maxillary vein and
deposited into a 2000µL microcentrifuge tube (Eppendorf) containing 50 µL of
heparin (Sagent Pharmaceuticals, Schaumburg, IL).
100µL of blood/heparin were washed in 1 ml Hank’s buffered saline
solution (HBSS; Corning CellGro), supplemented with 0.5% FBS (Invitrogen) and
0.1% sodium azide (J.T. Baker/Avantor). Prior to analysis, Fc receptors were
blocked with 2.4G2, red blood cells were lysed with BD Pharm Lyse (BD
Biosciences) and then cells were stained and analyzed for surface expression of
CD4, CD8, CD19, CD11b, CD-3, Gr-1 and CD45 (see antibody section for
details). Because CD4+CD8+ cells are normally found only in the thymus, any
blood samples with populations of CD4+CD8+ were eliminated from our analyses
(Fig. 10).
Throughout the experiment, tissue samples were harvested from mice at
varying times. Mice were observed daily, and if a mouse appeared visibly ill
(slow-moving, apparent tumor growth), it was euthanized by CO2 inhalation
followed by cervical dislocation according to the AMVA guidelines (AVMA, 2013).
For some experiments, half of the mice were euthanized at week 8, and all
remaining mice were euthanized at completion of the experiment on week 12.
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After euthanasia, spleen and thymus were removed from individual mice,
mechanically dispersed in HBSS (Corning CellGro), supplemented with 0.5%
fetal bovine serum (Invitrogen) and 0.1% sodium azide (J.T. Baker/Avantor), and
passed through sterile Nitex nylon mesh (80µm; Wildco, Yulee, FL) to form single
cell suspensions. The cells were then depleted of red blood cells with lysis buffer,
Fc blocked with 2.4G2, then stained and analyzed for surface expression of CD3,
CD4, CD8, CD11b, and CD5.

Figure 10. One measure of sickness in mice is presence of DP (CD4+CD8+) cells in
peripheral blood. A) Flow cytometry plot of blood illustrating normal DP population; B)
Flow cytometry plot of blood illustrating DP population in excess of 2.5%; Mice
resembling B were eliminated from our analysis of bloods based on sickness, with DP
cells indicating presence of a metastatic thymoma. Figure originally included as
supplementary for Chapter 5 manuscript.

Placenta Harvest and Histology
Placentas were placed individually into processing/embedding cassettes
(VWR, West Chester, PA) and preserved in 10% Neutral Buffered Formalin
(VWR) for 48-72 hours, then transferred to 70% EtOH (Pharmco-AAPER,
Brookfield, CT). Sample mounting and hematoxylin and eosin (H&E) stain were
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completed at the CRI Histology Core Facility at the Medical College of
Wisconsin, Milwaukee, WI. Slides were examined by a minimum of two readers,
and areas of labyrinth and total placenta were calculated using ImageJ software
(Schneider et al., 2012), following published guidelines (Susiarjo et al., 2013).

In vitro LSK Short-Term Self-Renewal Assay
LSK cells were sorted as described above, and cells were placed in
StemSpan SFEM serum free media (Stem Cell Technology, Vancouver, BC,
Canada) supplemented with 100 ng/ml SCF (Peprotech). Five hundred cells per
well in multiple wells on a 96 well plate were seeded on day 0 with feeding of
fresh media and SCF occurring every two days. On days 3, 6, 9, 12, and 15, cells
were harvested in quadruplicate, stained for lineage and hematopoietic stem cell
surface markers as described above, and cells were acquired on the FACS Aria
III. Cell counts were obtained on the flow cytometer using counting beads (Life
Technologies) according to the manufacturer’s instructions.

OP9 Co-Culture System
OP9 bone marrow-derived stromal cells transduced with either GFP (OP9GFP) or Notch ligand delta-like 1-GFP-IRES (OP9-DL1) were a generous gift
from Dr. Juan Carlos Zúñiga-Pflücker (Department of Immunology, University of
Toronto, Sunnybrook, Ontario, Canada). From original cell lines, cells were
expanded and then frozen in 1.2 ml of sterile 90% FBS+10% DMSO.
Approximately one week prior to experiment, OP9-DL1 or OP9-GFP cells were
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thawed from liquid nitrogen and grown in OP9 complete media, expanding to
additional culture flasks (Corning) as needed to maintain sufficient growth space
and confluency. Three days prior to establishment of co-culture, OP9-DL1 or
OP9-GFP cells were plated into either 24-well or 96-well tissue culture treated
plates (Corning) and allowed to grow to approximately 80% confluency, in a
humidified 37oC incubator maintained with 5% CO2. Prior to introduction of LSK
cells, OP9 medium was added to the wells, supplemented with 5ng/ml Flt3L
(PeproTech, Rocky Hill, NJ) and 5ng/ml Interleukin-7 (PeproTech). Sorted LSK
cells were maintained in co-culture system for up to 15 days with media
replacement (complete OP9 medium, supplemented with 5ng/mL Flt3L and
5ng/mL Interleukin-7) occurring every three days of co-culture.
For initial measurement of lymphocyte differentiation, 4000 LSK cells were
plated in each well of a Costar 24 well cell culture plate (Corning) on day 0 and
were harvested from triplicate wells every other day starting on day 5 and ending
on day 15, diluting and expanding into new 80% confluent OP9-adherent wells
when counts exceeded 1 x 106 cells per well.
For limiting dilution analyses, OP9 stromal cells were treated with 5µg/mL
Mitomycin C (Acros Organics, Thermo-Fisher Scientific, Waltham, MA) 4-24
hours prior to initiation of co-culture. For Mitomycin C treatment, growth media
was removed from 80% confluent OP9-GFP or OP9-DL1 cells and replaced with
100 µL of complete OP9 medium with 0.1% Mitomycin C. After 30 minutes of
incubation at 37oC in darkness, the Mitomycin C/OP9 media was removed and
cells were washed five times with sterile Phosphate Buffered Solution (PBS)
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containing 2.5% FBS. On day 0, either 1, 3, 6, 10 or 30 cells were sorted into
individual wells of a Costar 96 well cell culture plate (Corning). Sorted LSK cells
were maintained in co-culture system for up to 15 days with media replacement
(complete OP9 medium, supplemented with 5ng/mL Flt3L and 5ng/ml Interleukin7) occurring every three days of co-culture. All wells were harvested and
analyzed for presence of cell surface markers on day 12 for OP9-DL1 co-cultures
and day 14 for OP9-GFP co-cultures as described above.

RNA Preparation
Hematopoietic cells from vehicle or TCDD-treated fetuses were isolated
and sorted in TRIzol (Life Technologies) from GD 7.5 yolk sac, GD 11.5 AGM,
and GD 14.5 fetal liver. 1-bromo-3-chloropropane (Sigma-Aldrich) was used to
separate RNA into the aqueous phase after centrifugation. Resulting pellet was
re-suspended in molecular-biology grade water. Yield and purity were quantified
spectrophotometrically on a NanoquantTM plate using OD260/OD280 ratio
(Tecan) and was either made into cDNA or stored at -80oC. RNA was subjected
to reverse transcription using Tetro cDNA Synthesis kit (Bioline) using both
anchored-oligo(dT) 18 priming and random hexamer priming options and was
stored at -20oC until day of assay.

Real-Time Quantitative Reverse Transcriptase PCR
Primers were selected using the Universal ProbeLibrary version 2.5 for
Mouse (Roche) and checked for specificity using Primer-Blast (NCBI). cDNA was
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used as a template in 20µl reaction consisting of 10µM of forward and reverse
primers and 10µl SensiFAST SYBR No-ROX (Bioline). Gene names, accession
numbers, and sequences are provided in Table 5. Relative expression change
was determined using 2ΔΔCt with standardization to housekeeping genes.
Samples were run in triplicate for each result on a Roche LightCycler480 system
(Roche Applied Science, Indianapolis, IN). Cycling conditions were 95oC for 2
min, followed by 45 cycles of 95oC for 5s, 60oC for 10s, and 72oC for 10s.
For reference genes B-actin and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), Universal ProbeLibrary Mouse Gene Assays (Roche
Applied Science, Indianapolis, IN) were used according to the manufacturer’s
directions.
Table 5. Gene name, accession number and primer sequence used for
qRT2PCR
Name

Accession

5'->3' Forward

5'->3' Reverse

Cyp1A1

NM_009992.4

ccaagaggaagggcatagg

gagcagctctgtggctgac

Cyp1B1

NM_009994.1

agccaggacaccctttcc

gcctgaacatccgggtatc

AHR

NM_013464.4

cgggttccctgctcagta

ccagaagttcaaagctccaaa

ARNT

NM_001037737.2

ccagatttcacgtcactcca

ttgggaagaacgagtcttgg

NM_013684.3

ggcggtttggctaggttt

gggttatcttcacacaccatga

1,3

NM_023281.1

gggaatggtttggaacacag

tgcgcacagcatcagatt

1,4

NM_013556.2

gtcaacgggggacataaaag

caacaatcaagacattctttcca

TBP

1,2

SDHA
HPRT
1

At least two housekeeping genes were used for each time point. Housekeeping genes were
selected for each day of development based on an initial analysis demonstrating no effect of
TCDD.
2
TBP housekeeping gene used on GD 7.5
3
SDHA housekeeping gene used on GD 11.5 and 14.5
4
HPRT housekeeping gene used on GD 7.5 and maternal liver
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Apoptosis of Thymocytes via APO-BRDUTM TUNEL Assay
Thymocytes were harvested from Notch1ICN-TG mice developmentally
exposed to vehicle control or 3µg/kg TCDD. One million thymocytes per well
were incubated overnight in 24 well plates (Corning) at 37oC and 5% CO2 in
RPMI (Life Technologies) supplemented with 10 mg/mL gentamycin (Gibco,
Grand Island, NY), 10% FBS (Gibco), and 0.5M 2-Mercaptoethanol (EMD).
Thymocytes were then stained for surface markers CD4 and CD8 as described
above. After a 15 minute fixation with 1% paraformaldehyde, thymocytes were
resuspended in 70% EtOH and frozen at -20o C overnight. A Terminal
deoxynucleotide transferase dUTP Nick End Labeling (TUNEL) assay was
performed following manufacturer’s protocol outlined in the Phoenix Flow
Systems, Inc. APO-BRDUTM Kit (San Diego, CA), eliminating the addition of
Propidium Iodide/RNase A Solution. Cells were analyzed on BD FACSAria III as
described above, using FSC-Area by SSC-Area for doublet exclusion, followed
by identification of thymocytes by presence of both CD4 and CD8. Anti-BrdU
cells were identified within the thymocyte population by FITC fluorescence.

Statistical Analysis
Statistical significance was determined and is denoted on graphs and
tables as a single asterisk for p≤0.05, two asterisks for p≤0.01 or three asterisks
for p≤0.001.
For precursor frequency calculations, we first determined an acceptable
threshold value for a positive response using wild type (C57BL/6) mice. The

54
percentage of CD4+CD8+ cells for each well (Fig. 11A) was used to discriminate
responsive from non-responsive wells. Using the extreme limiting dilution
analysis (ELDA) program (Hu and Smyth, 2009), T cell precursor frequencies
were calculated for CD4+CD8+ percentages at every point from 0.1% to 5.0% of
the total cell population. The ELDA program returns a Chi Square value for each
vehicle/TCDD frequency comparison. Chi Square values were plotted at each
percentage point against the matching cell population percentage (Fig. 11B). The
peak of this graph, where the Chi Square value indicated the greatest difference
between control and exposed wells, was determined to be a range including the
three highest peaks (2.0-2.8). The highest peak value was chosen (2.8%) and
used to determine progenitor frequency for both B and T lymphocyte precursors.
Data for the limiting dilution was analyzed and graphed according to the “limdil”
function contained in the “statmod” package in Rstudio (RStudio, 2012). Our
calculations are based on a compilation of all data from three replications of the
OP9-DL1 co-culture system and three of the OP9-GFP co-culture system.

A.

B.
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Figure 11. Positive growth score cut-off value was determined by graphing Chi
Square values.
A. The percent of DP (CD8+CD4+) cells were graphed against B. Chi Square values.
The highest peaks represent the appropriate range for labeling a positive result. Positive
counts were made per well and associated Chi Square values calculated by Hu, et al’s
ELDA software. Images show CD8+CD4+ quadrant (T cells), but similar methods were
employed for CD19+B220+ (B cells). Figure originally included as supplementary for
Chapter 3 publication.

For limiting dilution analyses using AHR transgenic mice, data sets were
cleaned prior to combination for final analysis. Because our yield of LSK cells
from KO fetuses was occasionally very low, we eliminated repeats that had fewer
than 20 wells of 30 cells per well. We then compared the remaining experiments
to the 95% confidence interval previously determined for TCDD-exposed
C57BL/6 mice (Ahrenhoerster et al., 2014). We eliminated any ELDA
experiments for which progenitor frequency exceeded 1 in 49.9, using that
number as indication that insufficient growth was achieved in the co-culture
system for unclear reasons.
Graphpad Prism (Graphpad Software, LaJolla, CA) was utilized for
analysis of variance with Dunnett’s t post-hoc tests, Log-rank (Mantel-Cox) test of
survival curve comparison, and graphical presentation of all other data.
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ABSTRACT

The process of hematopoiesis, characterized by long-term self-renewal
and multi-potent lineage differentiation, has been shown to be regulated in part
by the ligand-activated transcription factor known as the aryl hydrocarbon
receptor (AHR). 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a ubiquitous
contaminant and the most potent AHR agonist, also modulates regulation of adult
hematopoietic stem and progenitor cell (HSC/HPC) homeostasis. However, the
effect of developmental TCDD exposure on early life hematopoiesis has not been
fully explored. Given the inhibitory effects of TCDD on hematopoiesis and
lymphocyte development, we hypothesized that in utero exposure to TCDD
would alter the functional capacity of fetal HSC/HPCs to complete lymphocyte
differentiation. To test this hypothesis, we employed a co-culture system
designed to facilitate the maturation of progenitor cells to either B or T
lymphocytes. Furthermore, we utilized an innovative limiting dilution assay to
precisely quantify differences in lymphocyte differentiation between HSC/HPCs
obtained from fetuses of dams exposed to 3µg/kg TCDD or control. We found
that the AHR is transcribed in yolk sac hematopoietic cells and is transcriptionally
active as early as gestational day (GD) 7.5. Furthermore, the number of
HSC/HPCs present in the fetal liver on GD 14.5 was significantly increased in
fetuses whose mothers were exposed to TCDD throughout pregnancy. Despite
this increase in HSC/HPC cell number, B and T lymphocyte differentiation is
decreased by approximately 2.5 fold. These findings demonstrate that
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inappropriate developmental AHR activation in HSC/HPCs adversely impacts
lymphocyte differentiation and may have consequences for lymphocyte
development in the bone marrow and thymus later in life.
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INTRODUCTION
Hematological malignancies are the fifth most common cancer in the world
and include lymphomas, acute lymphoblastic leukemias, and myeloproliferative
neoplasms (Rodriguez-Abreu et al., 2007). These malignancies are the most
common childhood cancer and the incidence rate for both children and adults
has increased during the last 40 years (Howlader et al., 2013). One risk factor
identified for leukemia comes from epidemiological analysis of Vietnam War
military veterans exposed to the defoliant Agent Orange that was contaminated
with 2,3,7,8 Tetrachlorodibenzo-p-dioxin (TCDD) (Institute of Medicine, 2011). In
present day China, children living near electronic waste recycling facilities
experience daily exposure to a spectrum of dioxin congeners (Han et al., 2011;
Leung et al., 2011; Shen et al., 2010). Moreover, humans in industrialized
countries can be exposed to dioxins through daily intake of meat, dairy and
seafood (Kvalem et al., 2012; Liem et al., 2000). Thus, dioxin exposure continues
to represent a significant global public health issue with potentially greater
adverse effects for populations exposed during development because the effects
can be longer lasting and may occur at lower developmental doses (Dietert et al.,
2010; Hogaboam et al., 2007).
TCDD is the most potent agonist of the Aryl hydrocarbon receptor (AHR)
and is known to impact a spectrum of adverse health conditions including
malignancy, neurological disorders, and immune suppression (Institute of
Medicine, 2011). We and others have shown that exposure to TCDD leads to
thymic atrophy and impairs T lymphocyte development (Laiosa et al., 2003,
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2002). Recently, the AHR has been implicated in mechanisms required for
maintenance and differentiation of adult hematopoietic stem cells (Boitano et al.,
2010; Casado et al., 2010; Gasiewicz et al., 2010; Lindsey and Papoutsakis,
2012; Smith et al., 2013). However, AHR-dependent effects on fetal
hematopoiesis have received little recent attention despite the possibility that
exposure to AHR agonists early in life could lead to long-term defects of
hematopoietic stem cell self-renewal or differentiation.
Hematopoiesis is the process by which immature hematopoietic stem and
progenitor cells (HSC/HPCs) develop into mature blood and immune cells, and
during development this process is initiated in the yolk sac (Orkin and Zon, 2008;
Samokhvalov et al., 2007). In fetal mice, the anatomical location and timing of
hematopoiesis proceed such that the site of hematopoiesis migrates from the
yolk sac to the aorta-gonads-mesonephros (gestational day (GD) 8-9), followed
by the fetal liver and spleen (GD11-GD16). Ultimately HSC/HPCs localize to the
bone marrow, which remains the site of hematopoiesis throughout adulthood
(Orkin and Zon, 2008; Robin, C et al., 2003). In response to micro-environmental
signals in the stem cell niche, a proportion of the long-term HSCs begin
differentiation along multiple blood cell lineages, and become committed to more
specific effector cell fates (Luc et al., 2008). For example, progenitors referred to
as common lymphoid precursors that receive a signal through the transmembrane protein Notch1, further differentiate into T lymphocytes whereas B
lymphocytes are generated from common lymphoid precursors that fail to engage
Notch1 (Deftos et al., 2000; Zúñiga-Pflücker and Schmitt, 2005).
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There is a growing recognition that factors that disrupt the processes of
HSC self-renewal or multipotent lineage differentiation into immune effector cells
can have profound effects on long-term immunity (Seita and Weissman, 2010).
For example, mice developmentally exposed to TCDD display persistent immune
defects indicative of later-life autoimmune disorder (Mustafa et al., 2008) and an
inability to mount an effective immune response to viral insult (Head and
Lawrence, 2009; B A Vorderstrasse et al., 2004). Moreover, mice exposed during
the perinatal period to TCDD exhibit longer-lasting effects than adult-exposed
mice (Hogaboam et al., 2007).
While there is considerable evidence connecting adult TCDD exposure to
immune suppression, the target hematopoietic cell population and the
mechanism by which immune suppression after developmental exposure is
occurring have not yet been fully elucidated. Therefore, we set out to test the
hypothesis that developmental aryl hydrocarbon receptor activation by TCDD
modulates the capacity of hematopoietic stem cells to undergo lymphocyte
differentiation. In order to test this hypothesis, we co-cultured fetal liver
HSC/HPCs in an in vitro co-culture system designed to drive differentiation along
either the B or the T lymphocyte lineage. Our method of determining B or T
lymphocyte differentiation capacity is particularly innovative because we have
created an assay that is a hybrid of stem cell limiting dilution analysis and
traditional toxicological assay. Importantly, we can accomplish this while
approaching environmentally-relevant levels of TCDD exposure in utero. Using
this quantitative in vitro co-culture system, we found a significant decrease in the
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lymphocyte differentiation potential of HSC/HPCs developmentally exposed to
TCDD. This decrease in the ability of fetal HSC/HPC to complete normal
hematopoietic differentiation may increase risk for later-life hematological
diseases such as malignancies or stem cell exhaustion (Lento et al., 2013; Stein
and Baldwin, 2013).
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RESULTS
Developmental exposure to TCDD increases the number of hematopoietic
progenitor cells in the fetal liver.
Hematopoietic progenitor cells cultured in the presence of both agonist
and antagonistic AHR modulators lead to progenitor cell expansion in vitro and
these new selective AHR modulators hold promise for improved clinical stem cell
therapies and approaches (Boitano et al., 2010; Smith et al., 2013). However, in
vivo comparisons with the in vitro data are complicated by differences in dose of
the modulators, metabolism of the modulator, and presence of additional intrinsic
and extrinsic factors present in the hematopoietic stem cell niche that could
modulate progenitor cell differentiation and self-renewal. Thus, as a first step to
determine the effect of persistent developmental AHR activation on
hematopoiesis, we tested the effects of transplacental exposure to the nonmetabolizable AHR agonist TCDD on fetal liver HSC homeostasis. Specifically,
to determine if developmental TCDD exposure affects fetal HSCs, we used flow
cytometry to examine GD14.5 fetal liver cells from mice developmentally
exposed to either 3µg/kg TCDD or vehicle control administered to the pregnant
dam by gavage on GD 0.5 and 7.5. The percentage of HSC/HPC cells defined by
the absence of lineage markers and expression of Sca-1 and cKit (referred to as
LSK) is more than two-fold higher in the fetal livers of mice developmentally
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exposed to TCDD (Fig. 12). Furthermore, the absolute number of LSK cells per
fetus and the mean fluorescence intensity of Sca-1 containing cells is also
significantly increased in fetal livers of mice exposed to TCDD transplacentally
(Fig. 12C & 12D; p≤0.01).

Figure 12. Hematopoietic progenitor cell frequency and number increase following
developmental TCDD exposure in vivo. Pregnant C57BL/6 dams were exposed to
3µg/Kg TCDD or vehicle control throughout gestation and fetal liver cells were isolated
on GD 14.5. A) representative fetal liver c-Kit versus Sca-1 flow cytometry plots are
shown from vehicle- and TCDD-exposed dams. The numbers in each quadrant
represent the percentage of Lin- cells expressing cKit, Sca-1 or both. B) The percentage
of fetal liver LSK cells from vehicle- and TCDD-exposed dams are shown. C) The
percentage of LSK cells was multiplied by total fetal liver cell number to determine
absolute number of LSK cells. D) The mean fluorescence intensity of Sca-1+ cells. Open
histograms represent vehicle and shaded histograms represent TCDD. Data are
presented as the mean + SEM (vehicle n=9; TCDD n=10). Statistical differences were
determined by ANOVA and Dunnet’s t post-hoc test. An *** is used to denote statistical
significance with p≤0.001.
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The AHR is expressed and is transcriptionally active in fetal hematopoietic cells.
Alterations in the proportion of fetal HSC/HPC cells following TCDD
exposure is predicted to be due to AHR expression and transcriptional activation
in hematopoietic cells. Thus, gene expression of the AHR and its heterodimerization partner ARNT were analyzed in hematopoietic cells obtained from
yolk sac on GD 7.5, the aorta-gonads-mesonephros (AGM) on GD 11.5 or GD
14.5 fetal liver during early fetal development. The AHR was expressed at all
three time points and its gene expression was significantly increased in TCDDexposed fetuses relative to control fetuses on GD 11.5 (Fig. 13A; p<0.01). In
comparison, ARNT was relatively unchanged except in the maternal liver where
its expression was down modulated following 14.5 days of exposure (Fig. 13B).
Maternal liver was used as a control to demonstrate the dose and method of
TCDD-exposure (gavage) was sufficient to activate the adult AHR throughout the
14.5 day exposure window. Furthermore, induction of Cyp1A1 by TCDD
exposure in GD 11.5 AGM HSC/HPC cells suggests the AHR-ARNT heterodimer
is transcriptionally active in the fetus (Fig. 13C). Taken together, these data
demonstrate the potential of the ligand-activated AHR to impact hematopoiesis in
the fetus through transcriptional changes in gene expression.
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Figure 13. AHR and ARNT are expressed in fetal HSC/HPC cells and are
transcriptionally active. Pregnant C57BL/6 dams were exposed to 3µg/Kg TCDD or
vehicle control throughout gestation and HSC/HPC cells were sorted and RNA obtained
from the maternal liver or fetal yolk sac on GD 7.5, aorta-gonadal-mesonephros on GD
11.5 and fetal liver on GD 14.5. RNA was reverse-transcribed and cDNA PCR amplified
by quantitative real-time PCR. A) The TCDD-induced fold change of AHR gene
expression is shown for the three gestational time points and in maternal liver. The
housekeeping genes used for each developmental time point are indicated in Table 1. B)
TCDD-induced fold change for ARNT. C and D) The TCDD-induced fold change for
AHR-ARNT target genes Cyp1A1 and Cyp1B1. The black dot represents the average
fold change from two independent experiments with the error bars indicating the foldchange from each individual experiment. RNA was pooled from HSC/HPCs sorted from
an entire litter.

LSK cells obtained from GD 14.5 fetal livers exposed to TCDD have normal
growth potential in vitro
In order to determine if the increase in the LSK cell population in TCDDexposed mice was attributed to differences in their proliferative potential, LSK
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cells were sorted and cultured in vitro using serum free media optimized for
expansion of short-term self-renewing HSCs and HPCs. To obtain a pure
population of LSK cells, fetal livers from GD 14.5 mice were dissected and
mature CD24+ cells were depleted by J11d mediated complement dependent
lysis as previously described (Schmitt and Zúñiga-Pflücker, 2002). Subsequently,
cells were prepared for fluorescence activated cell sorting and isolated with
greater than 95% purity (Fig. 14A & 14B).
Once placed in culture, LSK cells were supplemented with the stem cell
growth factor (SCF), where there is an approximately 1000 fold expansion of LSK
cells over the course of a two-week culture period (data not shown). During the
initial phase of the culture period, there appeared to be a slight increase in the
proportion of LSK cells in the culture but this was not statistically significant (Fig.
14C-14D). Moreover, by the end of the culture, there were no differences
between the frequency and number of LSK cells obtained from vehicle or TCDD
exposed fetuses (Fig. 14C-14D). These data indicate that the process of shortterm self-renewal that is facilitated by this in vitro culture system is not a primary
target of in utero TCDD exposure.

68

69
Figure 14. LSK cells obtained from GD 14.5 fetal livers exposed to TCDD have
normal growth potential in vitro. LSK cells were sorted on the FACS Aria III following
J11d mediated complement-dependent lysis. A) The gating strategy for sorting is shown
and results from a pre- and post-sort representative sample are displayed. Briefly, viable
cells based on Sytox blue dead cell exclusion were first gated, followed by doublet
discrimination using Forward and Side scatter (FSC, SSC) height by width gating.
Fluorescence gating strategy is shown with top panels showing lineage staining versus
SSC-area. B) c-Kit+Sca-1+ events were sorted using the FACS Diva version 6.0
software purity mask. This sorting strategy was employed and purity was determined
(>95%; data not shown) for all subsequent experiments. After cell sorting, five hundred
LSK cells were grown in StemSpan SFEM media + 100 ng/ml SCF and cultured for 15
days. C) Representative histograms of lineage stained cells (CD11b, Ter-119, Gr-1,
B220, CD3) are shown for days 3, 6 and 9. LSK cells from Vehicle-exposed dams are
shown with a black line, and LSK cells from TCDD-exposed dams are illustrated in gray.
D) cKit versus Sca-1 expression in LSK growth cultures is shown for Vehicle (left hand
contour plots) or TCDD (right hand contour plots). The numbers in each quadrant
represent the percentage of viable Lin- cells. Experiment was repeated three times.

TCDD induces cell cycle arrest in in vitro generated thymocytes
We have previously demonstrated that thymocytes obtained from adult
mice exposed to TCDD undergo cell cycle arrest within hours of exposure
(Laiosa et al., 2003), and that this effect is due to activation of the AHR in the
hematopoietic cell population directly (Staples et al., 1998). Given the importance
of AHR signaling in HSCs (Boitano et al., 2010; Gasiewicz et al., 2010), and
thymic atrophy, a critical question that remains is what effect TCDD exposure
has on HSC differentiation into cells of the lymphoid lineage. Up until now,
answering this question has proven difficult because of the different anatomical
locations where hematopoiesis and thymopoiesis occur. However, by using the
OP9-DL1 in vitro system of thymocyte differentiation (Schmitt and ZúñigaPflücker, 2002), we can track the transition of hematopoietic stem and progenitor
cells into thymocytes and determine the effect of AHR activation on this process.
The first step in this process was to determine if OP9-DL1 in vitro generated
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thymocytes have TCDD sensitivity similar to that of thymocytes obtained in vivo.
This was accomplished by sorting unexposed LSK cells harvested from murine
fetal livers into OP9-DL1 co-cultures and maintaining cells for 12 days. On day
11, co-cultures were exposed to various concentrations of TCDD or DMSO
vehicle control. Twelve hours after exposure, BrdU incorporation within each
stage of thymocyte development was analyzed. We observed an equivalent
percentage and number of cells expressing CD44 and CD25 twelve hours after in
vitro TCDD exposure indicating the distribution of early thymocyte progenitor
populations within the co-cultures are unaffected by this short exposure (Fig.
15A). However, BrdU incorporation is significantly attenuated in the CD44-CD25+
(DN3) population of thymocyte progenitors (Fig. 15B; p≤0.05). Moreover,
significant reduction in BrdU incorporation can be detected in cultures exposed to
as low as 0.001nM TCDD (Fig. 15C; p≤0.05). Importantly, the nearly 50%
reduction in BrdU within the CD44-CD25+ and CD44-CD25- populations is highly
correlated with the TCDD-induced cell cycle inhibition observed in these specific
thymocyte progenitor populations in vivo (Laiosa et al., 2003).
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Figure 15. BrdU incorporation is decreased in TCDD-exposed thymocyte
progenitors derived from LSK cells grown in OP9-DL1 co-cultures. A)
Representative CD25 versus CD44 flow cytometry plots for day 12 OP9-DL1 co-cultures
exposed in vitro to vehicle or 1nM TCDD for 24 h. Numbers inside each quadrant
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represent the percentage of CD4-CD8- (DN) cells. B) Intracellular BrdU incorporation
was measured in each thymocyte progenitor population and representative BrdU
histograms are shown for the CD44-CD25+ population from one vehicle and one 1nM
TCDD exposed culture. C) The percent of BrdU+ cells for each population of thymocyte
progenitors 12 h after in vitro exposure to TCDD or vehicle. Cultures were dosed on day
11, and surface staining and intracellular BrdU staining was conducted on day 12.
Experiment was repeated two times. Data are presented as the mean + SEM with 6
wells analyzed per group. Statistical differences are determined by ANOVA and
Dunnet’s t post-hoc test. An * is used to denote statistical significance with p≤0.05.

Kinetics of DL1-mediated thymocyte differentiation are equivalent in control and
developmental TCDD-exposed HSCs
The demonstration that in vitro TCDD exposure in the OP9-DL1 – LSK coculture system models the in vivo response to TCDD suggested that this system
could be employed to follow the lymphocyte differentiation potential of LSK cells
exposed to TCDD in utero. Thus, pregnant dams were exposed to vehicle or
3µg/Kg TCDD on GD 0.5 and 7.5 followed by cell sorting of LSK hematopoietic
stem and progenitor cells on GD 14.5. LSKs were then placed into OP9-DL1 or
OP9-GFP control co-cultures and thymocyte or B lymphocyte differentiation was
tracked every two days in cultures seeded with either vehicle or TCDD-exposed
LSK cells. Following developmental exposure to TCDD, no statistically significant
difference was found in the rate of LSK maturation into thymocytes in OP9-DL1
co-culture when 4000 cells were plated per well (Fig. 16). Similar results were
found with B cell progenitors grown in co-culture with OP9-GFP cells (Fig. 17).
Notably, a slight but not statistically significant difference in the frequency of
CD4+CD8+ thymocytes produced by OP9-DL1 co-cultures was detectable
between the vehicle- and TCDD-exposed wells at the end of the culture period.
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This slight difference led us to conclude that any subtle variation may have been
obscured by the high number (4000) of starting LSK cells per well.

Figure 16: Fetal liver LSK cells co-cultured with OP9-DL1 bone marrow stromal
cells undergo thymocyte differentiation with similar kinetics following
developmental vehicle or TCDD exposure. Fetal liver LSK cells were isolated on
GD14.5 as described and placed into OP9-DL1 co-cultures. Beginning on day 6 of coculture, and continuing every other day, cells were harvested, counted, and stained with
fluorochrome-labeled antibodies directed against CD4, CD8, CD44, and CD25. A)
Representative CD4-CD8- gated cells were analyzed for the percentage of CD44 versus
CD25 from vehicle- and TCDD-exposed dams. The numbers in each quadrant represent
the percentage of viable cells within the CD4-CD8- gate. B) CD8 versus CD4 expression
on each day of the differentiation assay is shown. The numbers in each quadrant
represent the percentage of viable cells. Experiment was repeated five times.
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Figure 17: Fetal liver LSK cells co-cultured with OP9-GFP bone marrow stromal
cells undergo B lymphocyte differentiation with similar kinetics following
developmental vehicle or TCDD exposure. Fetal liver LSK cells were isolated on
GD14.5 as described and placed into OP9-GFP co-cultures. Beginning on day 6 of coculture, and continuing every other day, cells were harvested, counted, and stained with
fluorochrome-labeled antibodies directed against CD4 and CD8, and B220.
Representative flow cytometry plots were analyzed for the percentage of B220 versus
CD4 and CD8 from vehicle- and TCDD-exposed dams. The numbers in the bottom right
quadrants represent the percentage of viable B lymphocytes. Experiment was repeated
five times. Figure originally included as supplementary.

Developmental TCDD exposure decreases lymphocyte differentiation potential of
LSK cells
In order to precisely quantify the lymphocyte differentiation potential on a
per cell basis following developmental vehicle- or TCDD-exposure, a limiting
dilution approach was employed to the OP9 – LSK co-culture system. Following
prenatal TCDD exposure, exactly 1, 3, 6, 10, or 30 LSKs from GD 14.5 fetuses
were deposited by FACS into individual wells in 96 well plates containing OP9DL1 or OP9-GFP stromal cells. On day 12 for the OP9-DL1 co-cultures, cells
from individual wells were harvested and stained with the thymocyte surface
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markers CD4 and CD8 and the percentage of wells containing CD4+CD8+ cells
was recorded. We found 1 in 16.9 (95% CI: 14.2-20.2) LSK cells have T cell
potential compared with nearly 1 in 39.6 LSK (95% CI: 31.5-49.9) cells
possessing T cell potential from the developmentally TCDD-exposed fetuses
(Fig. 18A; Table 6; p<0.01). Developmental TCDD exposure was observed to
also reduce by nearly two-fold the B lymphocyte precursor frequency for LSK
cells as determined by day 14 OP9-GFP limiting dilution co-culture analysis (Fig.
18B; Table 7). Taken together, these data demonstrate that prenatal TCDD
exposure significantly decreases the number of fetal liver LSK cells with potential
to produce T and B lymphocyte progeny.
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Figure 18: Developmental TCDD exposure decreases lymphocyte differentiation
potential of murine fetal liver HSCs. Fetal liver LSK cells were isolated on GD14.5 as
described. Exactly 1 to 30 LSK cells were directly sorted into individual wells of a 96 well
culture plate containing a confluent layer of mitomycin C-treated OP9-DL1 or OP9-GFP
cells and maintained for 12 (DL1) or 14 (GFP) days. Individual wells were analyzed for
the generation of thymocytes (CD4+CD8+) or B cells (CD19+B220+). The number of
positive responses for each cell concentration was entered into the limdil package in R
Studio (RStudio, 2012) and plotted using ELDA software. A) Thymocyte wells from OP9DL1 co-cultures were scored as a positive response if ≥2.8% of total cells in the well
were CD4+CD8+. B) B-lymphocyte wells from OP9-GFP co-cultures were scored as a
positive response if ≥2.8% of total cells in the well were CD19+B220+. Precursor
frequency is reported in Tables 2 and 3. Vehicle samples are represented by red circles
(3 replicates) and TCDD-exposed samples are represented by blue filled circles (3
replicates). 95% CI is shaded around each treatment (vehicle-pink; TCDD-light blue;
p≤0.001).
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Table 6. Thymocyte progenitor frequencies after developmental exposurea

______________________________________________________________________________________________________________

Progenitor frequency (95% CI)

p-value

______________________________________________________________________________________________________________

Thymocyte vehicle

1 in 16.9 (14.2-20.2)b,c

Thymocyte TCDD
1 in 39.6 (31.5-49.9)b,c
≤0.001
______________________________________________________________________
a

Pregnant C57BL/6J mice were exposed on gestational days (GD) 0.5 and 7.5 to either 3µg/Kg of
TCDD or vehicle; fetal liver LSK cells were isolated on GD 14.5 as described.
b
Progenitor frequencies were calculated using the limdil package in R-Studio after 12 days of coculture with OP9-DL1 cells and as described in Fig. 5 legend.
c
Each limiting dilution was repeated three times and the total number of wells for each cell
concentration from all three experiments was pooled for the limdil analysis.

Table 7. B lymphocyte progenitor frequencies after developmental
exposurea

______________________________________________________________________________________________________________

Progenitor frequency (95% CI)

p-value

______________________________________________________________________________________________________________

B lymphocyte vehicle

1 in 28.0 (21.6-36.2)b,c

B lymphocyte TCDD

1 in 62.3 (44.0-88.2)b,c

a

≤0.001

Pregnant C57BL/6J mice were exposed on gestational days (GD) 0.5 and 7.5 to either 3µg/Kg of
TCDD or vehicle; fetal liver LSK cells were isolated on GD 14.5 as described.
b
Progenitor frequencies were calculated using the limdil package in R-Studio after 14 days of coculture with OP9-GFP cells and as described in Fig. 5 legend.
c
Each limiting dilution was repeated three times and the total number of wells for each cell
concentration from all three experiments was pooled for the limdil analysis.
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DISCUSSION
In the present study, we demonstrate that prenatal exposure to TCDD
causes alterations in fetal HSC/HPC homeostasis and lymphocyte differentiation.
As shown in a novel co-culture limiting dilution assay, the ability of HSC/HPCs to
differentiate into T lymphocytes is decreased nearly two and a half fold following
developmental exposure to environmentally-relevant levels of the AHR agonist
TCDD. This decrease in T lymphocyte differentiation ability occurs despite an
increase in the overall number of fetal liver HSCs on GD14.5. The consequences
of in utero activation of the AHR on HSC/HPC cell differentiation may provide
insight into a spectrum of later life blood disorders ranging from stem cell
exhaustion to leukemia (Seita and Weissman, 2010).
The observed increase in fetal LSK cells is consistent with studies
showing similar alterations in adult bone marrow, however, the in vitro co-culture
functional assay offers advantages compared with more traditional
immunotoxicological hematopoiesis assays. Previous research has used stem
cell transfer to determine the eventual differentiation ability of TCDD-exposed
cells (Casado et al., 2011; Fine et al., 1989). However, these methods use an
abundance of stem cells isolated from fetal livers and/or bone marrow. For
example, when seeding in vitro OP9 cultures with 4000 LSK cells a sufficient
number of LSK cells possessing T or B lymphocyte potential were present
impacting the sensitivity necessary for determining if in utero exposure to TCDD
impairs differentiation. It is possible that earlier LSK transfer experiments may
have the same effect. To overcome the obstacle an excess of cells in an assay
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may present, limiting dilution is used to determine frequencies of cells in a mixed
population that have a particular function and therefore is commonly used for
progenitor cell applications. The benefit of the in vitro limiting dilution co-culture
differentiation system that we use is the ability to track the progression of a single
HSC to its eventual progeny. Furthermore, numerous single cells from one
sample of sorted HSCs can be tested to determine a numerical differentiation
potential. This method allows focus not only on individual effects, but also on the
earliest steps in differentiation. While the frequency of lymphocyte differentiation
using the OP9 co-culture system has been determined using limiting dilution
analysis from hematopoietic precursors in mice (Balciunaite et al., 2005) and in
humans (De Smedt, Magda et al., 2011; Kyoizumi et al., 2013), this is the first
time it has been employed to test the effect of a developmental toxicological
exposure on a progenitor cell population’s ability to differentiate.
A limitation of the limiting dilution analysis is that cells identified by an
absence of lineage markers, and the presence of Sca-1 and cKit (LSK cells)
comprise a heterogeneous population of progenitor cells with a range of longand short-term self-renewal capacity. Thus one interpretation of this research is
that developmental exposure to TCDD causes a shift in the composition of longto more short-term self-renewing progenitor cells identifiable by the LSK surface
proteins. For example, LSK cells with long-term self-renewal potential have full
multi-lineage differentiation potential. In comparison, cells transitioning from longterm to short-term self-renewal still maintain multi-lineage potential. However,
their capacity to differentiate into any lineage becomes more restricted as they
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mature and can be biased away from production of the common lymphoid
precursors that directly produce lymphoid restricted cells. In support of this
interpretation, we performed a test of heterogeneity for each limiting dilution
experiment known as a log-dose slope test. We found that all treatment groups
produced a log-dose slope of less than 1 (data not shown). A slope less than 1
demonstrates that the fetal liver LSK populations tested are a heterogeneous cell
population (Hu and Smyth, 2009), with the TCDD-exposed fetuses producing a
LSK cell population with significantly more heterogeneity than controls.
In support of the conclusion that developmental TCDD exposure changes
the composition of the self-renewal potential of fetal LSKs, we observe higher
Sca-1 expression on GD 14.5 (Fig. 12). Others have correlated high levels of
Sca-1 expression with decreased differentiation in the erythroid lineage (AzaleaRomero et al., 2012) and decreased ability to form myeloid colonies (Bradfute et
al., 2005) as well as patterns of decreased T cell lymphopoiesis in constitutivelyexpressing Sca-1 transgenic mice (Bamezai et al., 1995). Furthermore, in a
mouse model for the autoimmune disease lupus, up-regulation of Sca-1
correlated with a more severe disease state (Kumar et al., 2005). Taken
together, this supports Sca-1 as a potential target identifying loss of multi-lineage
differentiation due to developmental exposure to TCDD. The higher mean
fluorescence, and thus protein expression of Sca-1 could predict an increased
risk of hematopoiesis defects over the life-course.
In summary, we have for the first time demonstrated that prenatal
exposure to the environmental toxicant and AHR agonist TCDD significantly
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increases the number of HSCs, but on a per-cell-basis decreases the ability of
fetal liver LSK cells to differentiate into B and T lymphocytes. As with in vivo
experiments, the cell cycle effects of TCDD exposure were shown to be the most
dramatic in the DN3/DN4 stage of thymocyte differentiation in vitro. We used a
lymphocyte differentiation assay combined with extreme limiting dilution analysis
(Hu and Smyth, 2009) to follow prenatally-exposed LSK cells from the progenitor
stage through to lymphocyte commitment, arriving at a numerical differentiation
potential. The in vitro co-culture assay allowed us to focus on TCDD’s effect on
only the LSK cells, without any potential cross-signaling from TCDD-exposed
supporting tissues. Additionally, the single cell sorting procedure enabled us to
examine one LSK cell at a time to determine its ability to differentiate into a
lymphocyte. Utilization of an in vitro co-culture system to test the effects of
developmental toxicological exposures on hematopoietic stem cells is not only
novel, but also preferable to some types of in vivo studies due to the fast, concise
measures of immunological impact. Our approach to determining lymphocyte
differentiation potential could be modified to test the developmental
immunotoxicological effects of other compounds. Finally, this approach could
facilitate analysis of the sensitivity of other tissue-specific stem and progenitor
cells to developmental exposures.
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ABSTRACT
Environmental exposures during gestation can profoundly affect future
disease development. Immune cells, along with all other blood cells, descend
from hematopoietic stem cells (HSCs), which are formed in utero. Exposure to
2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD) in utero has previously been shown
to decrease the potential of fetal liver HSCs to differentiate into mature
lymphocytes and to shift the balance of adaptive and innate immune response in
adult offspring. However, it is not known whether these effects are due to fetal or
maternal factors. We hypothesized that persistent developmental aryl
hydrocarbon receptor (AHR) activation in the fetal HSCs was responsible for the
immune dysfunction, as TCDD is a potent AHR agonist. HSCs were harvested
on GD 14.5 from gene-targeted mutant AHR mice developmentally exposed to
3 µg/kg TCDD or vehicle control. HSCs were quantified and placed into T
lymphocyte differentiation cultures using a limiting dilution approach. We found
the ability for HSCs to differentiate into mature thymocytes is mediated by the
AHR in the individual fetuses. Specifically, the T cell differentiation potential of
HSCs from TCDD-exposed fetuses lacking an AHR is similar to that of HSCs
from vehicle-exposed wild type fetuses. Conversely, the TCDD-exposed siblings
who had an AHR produced HSCs with a diminished T cell precursor potential.
These data suggest that developmental AHR activation in HSCs reprograms the
balance between self-renewal and differentiation, potentially affecting immune
system development and function later in life.
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INTRODUCTION
Hematopoietic stem cells (HSCs) are the foundational cells of the blood
system, responsible for maintenance of all cells in the blood and immune system
by balancing the processes of self-renewal and lineage differentiation to produce
mature effector cells. The process of hematopoiesis maintains these immune
cells throughout a person’s lifetime. Consequently, there is a growing recognition
that factors that disrupt the processes of HSC self-renewal or differentiation can
have profound effects on long-term immunity (Seita and Weissman, 2010;
Yamada et al., 2013). For example, transplacental exposure to the ubiquitous
environmental contaminant 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD) leads to
numerous immunological deficits later in life.
TCDD, which is produced as a combustion by-product, mediates its
immunotoxicity in adult mice by binding to and activating the aryl hydrocarbon
receptor (AHR), an important regulator of immune system development and
function. AHR, a basic helix-loop-helix protein and member of the PAS family of
transcription factors, is a principle player in the detoxification pathway of many
environmental contaminants in addition to dioxins such as TCDD, specifically the
halogenated aromatic hydrocarbons, including polychlorinated biphenyls (PCBs),
aromatic amines, and polycyclic aromatic hydrocarbons (PAHs). The AHR is
evolutionarily conserved, and can be activated by either endogenous or
exogenous ligands (Smith et al., 2013).
AHR is known to be implicated in regulation of immune processes
including inflammation (Hanieh, 2014; Nguyen et al., 2013) and autoimmunity
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(Apetoh et al., 2010; Nguyen et al., 2013). The AHR is essential for immune
development, including regulating hematopoiesis (Casado et al., 2010) and
inducing regulatory T cells (N. P. Singh et al., 2011; Wu et al., 2011). However,
most immunological research using TCDD as an AHR agonist uses adult animals
or cell culture lines (Beedanagari et al., 2010b; Benson and Shepherd, 2011;
Casado et al., 2011; Kerkvliet, 2009; Laiosa et al., 2002; Takamura et al., 2010).
Almost all studies involving developmental TCDD exposures have focused only
on adult endpoints (Lew et al., 2009; B A Vorderstrasse et al., 2004) and not
directly on the HSCs. Understanding specifically the mechanisms by which AHR
activation during development causes immune system malfunction and where it
impacts hematopoiesis remains a significant knowledge gap.
The AHR is found in embryonic stem cells (Ko et al., 2014) and HSCs
(Singh et al., 2009), and we have found that it is up-regulated in HSCs on
GD11.5 following developmental exposure to 3µg/kg of TCDD (Ahrenhoerster et
al., 2014). Our earlier research illustrates that developmental dioxin exposure
decreases the ability of HSCs to differentiate into B or T lymphocytes
(Ahrenhoerster et al., 2014). However, whether this is due to AHR activation in
the fetus, the placenta, or the mother has yet to be elucidated. Therefore we set
out to determine the mechanism by which the decreased differentiation occurs,
hypothesizing that the AHR in fetal HSCs is directly affected by exposures during
gestation.
In order to test this hypothesis, we co-cultured fetal liver HSCs, defined as
Lin-, cKit+, Sca-1+ (LSK) cells, in an in vitro system designed to drive thymocyte
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differentiation. LSKs were isolated from fetuses of AHR heterozygous (HZ;
AHR+/-) x AHR knockout (KO; AHR-/-) or HZ x HZ crosses, thus producing
siblings of different genotypes while holding all other variables related to
development constant. Using limiting dilution analysis to examine the
differentiation potential, we found a significant decrease in the thymocyte
differentiation potential of HSCs developmentally exposed to TCDD and isolated
from fetuses possessing AHR. HSCs isolated from fetuses from the same mother
but lacking AHR did not exhibit a decreased differentiation potential. This model
is especially robust as it allows us to focus on AHR activation in the fetus while
providing a uniform uterine environment during gestation. These findings support
the role of AHR in the fetus as a target of TCDD developmental immunotoxicity.
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RESULTS
The question of whether AHR gene dosage impacts response has been
considered by us and other researchers. Others have shown no response
difference between AHR+/+ (wild type; WT) or AHR+/- (HZ) mice, as both
possess the AHR+ allele (K. P. Singh et al., 2011). We similarly found no
significant difference in co-culture growth potential (unpublished data), so in our
experiments, we combined AHR+/+ with AHR+/- to represent AHR+ HSCs and
compared them to AHR- HSCs, consisting entirely of AHR-/- (KO).

HSCs from AHR+ fetuses developmentally-exposed to TCDD showed a
decreased potential to differentiate into mature thymocytes in comparison to
HSCs from AHR- fetuses developmentally-exposed to TCDD.
Developmental exposure to the potent AHR agonist TCDD in C57BL/6
(WT) mice decreases lymphocyte differentiation potential, and the AHR is
expressed and transcriptionally active in fetal HSCs (Ahrenhoerster et al., 2014).
We therefore hypothesized that the differentiation impairment following
developmental TCDD exposure is due to activation of the AHR in the fetus, thus
impacting HSCs at a very early timepoint in development.
Among TCDD-exposed siblings developing in the same uterine
environment, the HSCs from AHR- fetuses were over two-fold more likely to
complete differentiation into mature thymocytes than HSCs from their AHR+
siblings (Fig 19A & C). This supports the hypothesis that the differentiationlimiting actions of TCDD are acting through the AHR in fetal HSCs and that the
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absence of an AHR provides an element of protection to the HSCs exposed to
TCDD during thymocyte commitment.
In order to further clarify our initial findings that the AHR must be present
in order for TCDD to cause decreased differentiation of HSCs, we further
hypothesized that HSCs isolated from either AHR+ or AHR- fetuses
developmentally exposed to vehicle control throughout gestation would have
comparable thymocyte differentiation potential. Using limiting dilution analysis,
we measured the differentiation potential of HSCs isolated from sibling AHR+
and AHR- fetuses developmentally exposed to vehicle control. We found that
HSCs from vehicle-exposed AHR+ and AHR- fetuses did not differ in thymocyte
differentiation potential (Fig. 19B & 19C).
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A.

B.

C.

Figure 19. Presence of fetal AHR decreases lymphocyte differentiation potential of
murine fetal liver HSCs exposed developmentally to TCDD, while vehicle-exposed
HSCs show no difference in differentiation potential regardless of AHR presence.
Fetal liver LSK cells were isolated on GD14.5 as described. Exactly 1 to 30 LSK cells
were directly sorted into individual wells of a 96 well culture plate containing a confluent
layer of mitomycin C-treated OP9-DL1 cells and maintained for 12 days. Individual wells
were analyzed for the generation of thymocytes (CD4+CD8+). The number of positive
responses for each cell concentration was entered into the limdil package in R Studio
(RStudio, 2012) and plotted using ELDA software (Hu and Smyth, 2009). Thymocyte
wells from OP9-DL1 co-cultures were scored as a positive response if ≥2.8% of total
cells in the well were CD4+CD8+. A) HSCs isolated from fetal mice developmentally
exposed to 3µg/kg of TCDD throughout gestation (pooled data from 5 separate
experiments); B) HSCs isolated from fetal mice developmentally exposed to vehicle
control throughout gestation (pooled data from 3 separate experiments); C) Calculated
precursor frequency; AHR- samples represented by orange and AHR+ samples
represented by green; 95% CI is indicated by a color-matched shaded area around each
treatment.
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AHR knock-out fetuses are slightly less likely to survive to parturition.
Through the duration of limiting dilution experiments with AHR transgenic
mice, the number of KO fetuses was anecdotally observed to be smaller than the
number of either WT or HZ fetuses. We recorded the genotypes of all AHR
variant fetuses as genotyped during all repeats of this experiment and observed
genotype ratios were compared to expected genotype ratios using Chi square
analysis (Table 8). We found that on average there were fewer KO fetuses than
expected based on predicted Mendelian inheritance ratios, although none of the
values reached levels of significance at the p≤0.05 value.

Table 8
Genotype results of offspring from AHR transgenic matings

1
2

Paternal GT1

treatment

#WT

#Het

#KO p-value2

HZ
HZ
KO
KO
HZ
KO

vehicle
TCDD
vehicle
TCDD
vehicle + TCDD combined
vehicle + TCDD combined

40
23
63
-

68
28
21
12
96
33

33
14
11
8
47
19

0.65
0.15
0.11
0.50
0.18
0.07

Maternal GT in all cases was HZ
p-value calculated by Chi-square analysis, comparing observed to expected genotype ratios

Litters fathered by AHR KO mice are significantly less likely to survive until
parturition.
We observed in the AHR transgenic mice, anecdotally, a high number of
fetal reabsorptions or spontaneous abortions, determined by masses of tissue in
the uterus which are significantly smaller than viable fetuses. It was noted that in
these experiments, a larger percentage of fetal reabsorptions were observed
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when the father was a KO male than in uteri of exclusively WT x WT vehicle
mice, reported as 9.69% ± 11.6% in the literature (Kusakabe et al., 2008), and
similarly observed as 9.12% ± 11.7% in our laboratory (unpublished observation).
We attempted to genotype the tissue masses that were in the process of
being reabsorbed, but the placenta is a mixture of fetal and maternal tissue which
we were unable to separate. Given that all mothers were HZ, all electrophoresis
gel genotype results showed double bands, representative of the HZ genotype.
However, the mean number of fetal reabsorptions per litter with a HZ father was
1.08, while with a KO father, it was 2.56 (p≤0.05). Additionally, while the
percentage of fetal reabsorptions from a HZ father was not significantly different
from WT x WT matings (Z-test; p=0.39), it was significantly higher when the
father was a KO (Table 9; Z-test; p≤0.05). Interestingly, adding the number of
reabsorbed fetuses to the number of KO fetuses brings the genotype ratio closer
to the expected 50% with KO father and 25% with HZ father (Tables 8 and 9).

Table 9
Reabsorbed fetuses (spontaneous abortions) by parental genotype
Maternal GT

Paternal GT

# reabsorbed % reabsorbed

p-value*

HZ
HZ
WT

HZ
KO
WT

19
22
36

0.20
0.01
0.14

12.3%
19.4%
7.6%

*p-values based on z-test comparing percent reabsorptions to published vehicle WT reabsorption
percentages (Kusakabe et al., 2008)
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Genotype does not affect size of maternal and fetal sections of placentae.
Because we saw an increase in the number of fetal reabsorptions when the
father was AHR- and because the number of viable fetuses trended toward
AHR+, we hypothesized that a higher percentage of AHR- fetuses were not
surviving gestation. Perturbation of cell death or proliferation-related proteins
might deter the growth and maintenance of the placentae, driving subsequent
fetal reabsorption. Furthermore, placental development has been used as a
measure of genetic or epigenetic defect (Susiarjo et al., 2013), potentially
resulting in a failed placenta followed by fetal death and reabsorption. We
collected, preserved, and stained placenta samples from each AHR genotype of
fetuses at GD14.5 and then measured the fetal and maternal regions of the
placenta using the methods previously described (Susiarjo et al., 2013) (Fig. 20A
& B). We did not find a significant difference between the various genotypes (Fig.
20C, p=0.37) at GD14.5. However, in consultation with Dr. Martha Susiarjo
(Susiarjo, 2014), and also with placental pathologist Dr. Sara Szabo (Szabo,
2014), we determined that GD14.5 is too late developmentally to witness
breakdown of the placenta. GD 11.5 or earlier coincides with early placental
failure and histological identification of abnormality that may lead to fetal death
and reabsorption. Additionally, one of the most accurate means of determining
placental insufficiency is by comparing mass of placenta in each experimental
group--a procedure we had not followed. Our lab’s future developmental work
with mice will include addition of earlier harvest timepoints and placental weights
(Fig 21).
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A.
Junctional ZoneMaternal region
Labyrinthine ZoneFetal region

B.

C.

Figure 20. Labyrinth to placenta area ratio does not differ by genotype on GD14.5.
Labyrinth is fetal portion of placental, as identified by presence of nucleated red blood
cells. “Placenta” measurements include both the fetal and maternal portions illustrated in
A and B. A) Representative section of a placenta harvested on GD14.5 viewed at the
magnification necessary to differentiate maternal and fetal sections (40x); B) Crosssection of full placenta, piecing together numerous sections at lower magnification to
illustrate placement on a full placenta (100x). No actual measurements were made at the
lower magnification. C) Mean ratio of labyrinth (fetal) to full placenta (fetal + maternal
regions) (p=0.37; n=3 of each genotype).
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Figure 21. Mean placental weight differs between mice developmentally exposed
to TCDD or vehicle control. Data from one sample experiment, illustrating the varied
masses of placentae harvested on GD11.5 from WT mice developmentally exposed to
either 3µg/kg TCDD or vehicle control. (n=8 vehicle; n= 22 TCDD; p≤0.01)
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DISCUSSION
In the present study, we demonstrate that prenatal exposure to
environmentally-relevant levels of TCDD acts through the fetal AHR to cause an
alteration in lymphocyte differentiation ability. We show that a lack of AHR
provides protection against the effects of developmental TCDD exposure, and
that HSCs isolated from TCDD-exposed AHR- fetuses are able to complete T
lymphocyte commitment at a frequency similar to HSCs developmentally
exposed to vehicle control. After developmental TCDD exposure, HSCs from
AHR+ mice, gestated in the same maternal environment as AHR- mice, exhibited
a roughly two-fold decreased ability to commit as T lymphocytes, thus supporting
the role of the fetal AHR in lymphocyte differentiation.
While our original hypothesis was supported, we are less than fully
confident in our results, due to several inconsistencies in the data. AHR KO mice
have deficiencies in multiple systems (Fernandez-Salguero et al., 1997). Given
that the AHR is located in almost all murine and human tissues, additional,
additional non-hematological defects likely exist, which might explain our
difficulties in achieving consistent results throughout our experimental repeats.
In our experiments, we crossed HZ dams with either HZ or KO males,
resulting in both AHR+ (HZ and WT) and AHR- (KO) fetuses housed in AHR+
mothers, to decrease external effects and to enable us to focus on fetal effects
alone, controlling for any potential maternal factors that might alter development
and/or hematopoiesis. We relied heavily on male AHR KO mice in order to
increase the likelihood of KO fetuses and provide greater power to our HSC
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differentiation calculations. HZ x HZ crosses have published 1:2:1 ratios of
WT:HZ:KO (Schmidt et al., 1996), but the AHR has recently been implicated for
its role in embryonic development (Ko et al., 2014; Sartor et al., 2009). While
research shows that activation of the AHR can cause defects in development,
absence of the AHR might also affect development. The lower number of AHRfetuses found on GD14.5 supports the likelihood that AHR KO males have
multiple defects, including reproductive ones. AHR KO males do display defects
in seminiferous tubule and sperm development and are less likely to fertilize eggs
(D. A. Hansen et al., 2013). It is therefore possible that fewer eggs were
successfully fertilized or that those which were fertilized had genetic defects that
resulted in spontaneous abortion. In fact, our counts of fetus size support this, in
that AHR litters are slightly smaller than C57BL/6 litters, though not at a
statistically significant level (data not shown). The HZ mothers were able to carry
litters to term, so the defect does not seem to be entirely dependent on them and
any maternal effect would be constant throughout these experiments, regardless
of paternal genotype. We are not the first to notice the variations in genotype
ratio (Hirabayashi and Inoue, 2009), although others posit that the lower KO
ratios are due to competitive fertilization by AHR+ sperm instead of the demise of
KO fetuses.
In order to reach sufficient power in our limiting dilution experiments, the
results from several experiments were combined, and in all but one case, we
examined only vehicle-exposed or only TCDD-exposed cohorts on any given
day. The TCDD-exposed cohorts each gave very similar results with little
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variation. However, we completed over twice as many vehicle-exposed
experiments in order to establish consistent repeats. As described in the
“Materials and Methods” section, we eliminated experiments with insufficient
HSC co-culture growth, as defined by a calculated differentiation potential in
excess of the published 95% confidence interval for WT TCDD-exposed HSCs
(Ahrenhoerster et al., 2014). We further eliminated experiments lacking sufficient
harvest of LSKs to sort a minimum of twenty 30-count wells. Additionally, the
data points for the vehicle-exposed mice, while overall consistent, did not fit the
graph constructed by the ELDA program as tightly (Fig. 19B) as did the points on
the TCDD-exposed graph (Fig. 19A).
It is possible that we saw less variation in experiments with the TCDDexposed cohorts because the presence of the potent AHR agonist TCDD is a
stronger decision-maker in terms of lineage commitment than other endogenous
mechanisms. Therefore, without the presence of this strong AHR agonist, the
whole-organism defects of the AHR KO model become the predominant lineage
decision-maker. Our work with this particular whole-mouse AHR KO model has
posed several new questions about determination of AHR’s effect on
hematopoiesis in the fetus.
One possibility, recently illuminated by the NIH Revitalization Act (Clayton
and Collins, 2014), is related to the gender effect. Perhaps developmental TCDD
exposure or AHR activation has a different effect in females than in males. TCDD
is a known estrogen disruptor (Safe et al., 1998), and all mothers were HZ, so
AHR+. Our rapid AHR genotyping allowed us to pool fetal livers to increase yield
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of HSCs, but we did not genotype for fetal gender, so some alterations in
response might also be gender-dependent. Any differences observed in the
TCDD-exposed fetuses may have been modified by endocrine responses.
Furthermore, without knowing fetal gender, we don’t know if one genotype group
had more of a single gender, or, indeed, if the fetal survival is affected by gender.
If TCDD, as an endocrine disruptor, biases the sex ratio within a litter, then the
TCDD-exposed fetuses would have comprised a more uniform gender group
without our knowledge. The lack of variability in the TCDD-exposed experiments
supports this explanation. Similarly, it is possible that AHR is not required for
gender determination, but its presence or absence may influence gender. Future
work with these mice should incorporate fetal sex determination.
There is increasing understanding that the intrauterine environment has
great impact on the developing fetus. This applies not only to exposure to
maternal nutrition and exposure to environmental contaminants, but potentially
also to factors such as placement in the uterus. Most definitively, it has been
shown that testosterone-related gender effects appear in mammal fetuses based
on the gender of neighboring fetuses. Indeed, uterine position affects genderrelated anatomy such as anogenital distance (Ryan and Vandenbergh, 2002),
physiology including levels of testosterone and estrogen (Vandenbergh and
Huggett, 1994; vom Saal, 1989) and gender ratio of future offspring
(Vandenbergh and Huggett, 1994), and behavior including novelty-seeking
behavior (Palanza et al., 2001) and aggression (Ryan and Vandenbergh, 2002).
Furthermore, in rats this effect is enhanced by a single gestational dose of TCDD
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(Timms et al., 2002). This concept, known as the “womb-mate effect,” has been
examined in other phenotypes as well. For example, murine fetal circulation is
negatively affected by gestational location near a dead/reabsorbed fetus or a
fetus with a different genotype (Raz et al., 2012). Because our litters were mixes
of WT, HZ and KO fetuses, in some cases a KO might have been located
between two WT or HZ fetuses in the uterus. Given the fact that AHR is involved
in multiple developmental pathways, even though the KO fetus lacked any AHR
alleles, its proximity to an AHR+ fetus (or a reabsorbed fetus) might have
affected its development and therefore the response of its HSCs. Interestingly,
our results from the limiting dilution analyses using HSCs from vehicle-exposed
fetuses (Fig. 19B) did not fit the ELDA model as well as those from TCDDexposed mice (Fig. 19A). It is possible that some of the intrauterine effects
described here were responsible for the variability seen from experiment to
experiment in vehicle-exposed mice. When developmental TCDD exposure was
added into the mix, it became the predominant determinant of HSC fate,
overriding lesser effects based on gender or uterine position.
Overall, the evolution of AHR appears to benefit longevity in multiple ways
(Hirabayashi and Inoue, 2009), and therefore it should not be surprising that the
AHR KO model that we used for our research had numerous complications. One
way to overcome these difficulties would be to switch to a mouse model that is a
conditional knock-out, which maintains the functionality of AHR for fertility,
development, and general longevity, but that lacks the AHR in hematopoietic
cells. This would allow our observations to focus on the hematopoietic effects,
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and also decrease the number of mice required to reach significant power in our
experiments.
The experiments outlined in this chapter provide the first steps in
definitively showing that the decreased lymphocyte differentiation following
developmental TCDD exposure that our lab previously observed (Ahrenhoerster
et al., 2014) is brought about due to the presence and activation of AHR in the
fetus. Many of these findings will drive future work in the lab in terms of
understanding the limits of the AHR full KO model and can increase the
usefulness of limiting dilution analysis in testing developmental immunotoxicity of
other environmental contaminants.
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ABSTRACT

Over half of T-cell acute lymphoblastic leukemia (T-ALL) patients have
activating mutations in the Notch gene. Moreover, the contaminant 2,3,7,8
Tetrachlorodibenzo-p-dioxin (TCDD) is a known carcinogen that mediates its
toxicity through the aryl hydrocarbon receptor (AHR), and crosstalk between
activated AHR and Notch signaling pathways has previously been observed.
Given the importance of Notch signaling in thymocyte development and T-ALL
disease progression, we hypothesized that the activated AHR potentiates
disease initiation and progression in an in vivo model of Notch1-induced
thymoma. This hypothesis was tested utilizing adult and developmental exposure
paradigms to TCDD in mice expressing a constitutively active Notch1 transgene
(NotchICN-TG). Following exposure of adult NotchICN-TG mice to a single high dose
of TCDD, we observed a significant increase in the efficiency of CD8 thymocyte
generation. We next exposed pregnant mice to 3µg/kg of TCDD throughout
gestation and lactation to elucidate effects of developmental AHR activation on
later-life T cell development and T-ALL-like thymoma susceptibility induced by
Notch1. We found that the vehicle-exposed NotchICN-TG offspring have a
peripheral T-cell pool heavily biased toward the CD4 lineage, while TCDDexposed NotchICN-TG offspring were biased toward the CD8 lineage. Furthermore,
while the vehicle-exposed NotchICN-TG mice showed increased splenomegaly
and B to T cell ratios indicative of disease, mice developmentally exposed to
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TCDD were largely protected from disease. These studies support a model
where developmental AHR activation attenuates later-life Notch1-dependent
impacts on thymocyte development and disease progression.
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INTRODUCTION
In humans, rates of chronic immune diseases and disorders have
progressively increased over the last forty years (Bach, 2002; Dietert et al., 2010;
Howlader et al., 2013; Jacobson et al., 1997). Some have suggested the
increase in immunodeficiencies is due to the interaction of the environment with
genetic susceptibility factors leading to altered immune state or immune cell
development (Fazekas de St Groth, 2007; Perl, 2010). Environmentally initiated
alterations in developmental pathways may lead to latent disease risk that can
emerge at any time later in life following secondary exposures (Barker, 2007;
Gluckman, Peter D. et al., 2005; Schug et al., 2012). Therefore, children are
more vulnerable than adults to such exposures, as they have the entire life
course ahead of them, resulting in more opportunities to impact sensitive time
points (Perera and Herbstman, 2011). Environmental factors that are present
during early life developmental stages may have particularly long-ranging impact
by developmentally reprogramming progenitor cells through epigenetic changes
at the chromatin level that potentially impact gene expression later in life. The
impacts of progenitor cell reprogramming on later-life disease susceptibility are
dependent on the interaction between the maternal intrauterine environment, the
timing of exposure to potential insults, and the genetic susceptibility of the child.
For example, early mutations in hematopoietic stem cells can increase the risk
for development of leukemia (Corces-Zimmerman and Majeti, 2014). Moreover,
60% of all cases of T cell acute lymphoblastic leukemia (T-ALL) are associated
with activating genetic mutations in Notch1 (Van Vlierberghe and Ferrando,
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2012; Weng et al., 2004), a transmembrane receptor required for T cell
development and function and regulation of CD4 vs. CD8 lineage commitment
(Fowlkes and Robey, 2002).
Pinpointing environmental exposures as risk factors linked directly to
disease outcomes is often complicated because of the latency associated with
chronic, low level exposures. However, developmental exposure to the
ubiquitous, persistent contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),
acting through the aryl hydrocarbon receptor (AHR), has been connected to
immune dysfunction later in life (Dietert, 2009; Vorderstrasse et al., 2004), and
epidemiological studies that have followed the population in Seveso, Italy
accidentally exposed to TCDD in 1976, show an increase in both lymphatic and
hematological cancers in adults (Consonni et al., 2008). Furthermore, children
whose parents had elevated TCDD in their serum exhibited a decrease in thyroid
function (Eskenazi et al., 2010). These results suggest that the adverse effects of
TCDD can occur following both acute adult exposure and chronic low level
developmental exposure and that the developing immune system is a sensitive
target of TCDD in humans.
A potential connection between the AHR and Notch was elucidated in
human acute lymphoblastic leukemia (ALL) where hypermethylation of the AHR
promoter region was observed (Mulero-Navarro et al., 2006). Additionally, AHR
responsive elements (AHREs) have been found in Notch promoters (Bock,
2013), and Notch signaling induces stimulation of the AHR in activated T cells
(Alam et al., 2010). However, whether Notch1 and developmental AHR
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activation interact to promote disease has yet to be determined. This potential of
developmental Notch1-AHR crosstalk during hematopoietic system disease
initiation warrants further consideration given the genetic link to Notch1 mutations
in T-ALL and continued production and persistence of TCDD and other
environmental combustion by-products that act on the AHR, particularly in many
developing countries undergoing rapid industrialization (Tanabe and Minh, 2010;
Terauchi et al., 2009; Tue et al., 2013).
Previously we have demonstrated that developmental exposure to TCDD
decreases the ability of hematopoietic progenitor cells to differentiate into mature
lymphocytes (Ahrenhoerster et al., 2014). To determine if this phenomenon
could have later-life disease implications, we examined the effect of prenatal
AHR activation by transplacental exposure to TCDD on development and
progression of a Notch1-induced thymoma in mice. We utilized a Notch1
transgenic mouse prone to developing T cell thymoma in order to probe a
potential Notch1-AHR gene-environment interaction in disease. We hypothesized
that developmental activation of AHR would produce a more severe form of
Notch1- influenced thymoma in transgenic mice prone to disease than in
unexposed control transgenic mice. To test this hypothesis, timed pregnant dams
were exposed to 3µg/kg TCDD or vehicle control throughout pregnancy and at
two days past parturition (PPD2). We found that while there was no significant
difference in disease onset, severity or incidence between the groups, there was
a significant difference in the ratios of circulating T-cells in the adult mice
developmentally exposed to TCDD, ultimately impacting the lineage of the
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thymomas identified in the peripheral immune organs. Specifically, whereas
unexposed Notch1 transgenic mice had a higher proportion of circulating CD4+
cells in the blood, Notch1 transgenic mice exposed to TCDD in utero had an
increased proportion of circulating CD8+ cells as adults. This T cell lineage
switch suggests an AHR-dependent reprogramming of a hematopoietic precursor
during development that impacts the later-life intrinsic Notch signal transduction
occurring in the CD4 versus CD8 T-cell lineage choice. These data have
implications for disease susceptibility in vulnerable populations that may possess
genetic instability in the Notch locus and/or have been exposed to environmental
AHR agonists developmentally.
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RESULTS
Notch1ICN-TG-dependent maturation of CD8+ thymocytes is potentiated by TCDD
activation of the AHR.
In order to elucidate the potential interaction between Notch1 and the AHR
during thymocyte development, we exposed four-week old Notch1ICN-TG and
C57BL/6 mice to a single dose of 10 or 30µg/kg TCDD or vehicle control, and
analyzed thymus size, cell number, and composition 10 days after exposure. The
Notch1ICN-TG transgenic mice utilized for these studies expresses the
constitutively active intracellular Notch1 under control of the lck-proximal
promoter, restricting its expression to developing thymocytes. These mice have
previously been shown to produce a larger percentage of CD8+ thymocytes than
CD4+ thymocytes, in contrast to proportions found in wild type C57BL/6 mice
(Robey et al., 1996). This increased population of CD8+ cells found in the
Notch1ICN-TG thymus is similar to observations made in mice exposed to the AHR
ligand TCDD (Gill et al., 2008; Kremer et al., 1995). Following exposure to
TCDD, both C57BL/6 and Notch1ICN-TG mice showed a significant decrease in
thymic weight and cellularity (Fig. 22A-B). Notably, we found that vehicleexposed adult Notch1ICN-TG mice had larger thymuses by weight (Fig. 22A) but
lower cellularity (Fig. 22B) than C57BL/6 mice. Examination of flow cytometry
FSC-A histograms for cell size distribution show a bi-modal peak in Notch1ICN-TG
mice compared to the C57BL/6 indicating there is a greater population of large
blast-like thymocytes (Fig. 23).
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Figure 22: Thymus cellularity and efficiency of thymocyte conversion in adult male
C57BL/6 or Notch1ICN-TG mice after administration of TCDD or vehicle control. Wild
type C57BL/6 or Notch1ICN-TG mice were administered 10µg/kg TCDD, 30µg/kg TCDD or
vehicle control via oral gavage at 4 weeks of age. Ten days later, mice were euthanized,
thymuses removed, single cell suspensions made, and cells stained with fluorescentconjugated antibodies directed against CD4 and CD8. Cells were acquired on a BD FACS
Aria III flow cytometer and data analyzed in FlowJo. A) Thymus weight ± SEM; B)
Thymocyte cellularity ± SEM; C-F) Absolute cell number (mean ±	
 SEM) in each thymocyte
cell population; G-H) Efficiency of SP (CD4+ or CD8+) generation, calculated by dividing
the number of CD4+ or CD8+ thymocytes in by the number of CD4+CD8+ precursors;
Vehicle mice are represented with white bars, 10µg/kg TCDD mice with black bars, and
30µg/kg TCDD-exposed mice with gray bars. A single * indicates p≤0.05; ** indicates
p≤0.01; *** indicates p≤0.001. All compared to vehicle control within genotype unless
otherwise indicated by bracket. (n=at least 4 B6 mice in each group; n=at least 8
Notch1ICN-TG mice in each group)

A.

C57BL/6 mice

B.

Notch1ICN-TG mice

Figure 23. Thymocytes from Notch1ICN-TG mice exhibit a bimodal forward scatter
histogram. Thymocytes were isolated from Notch1ICN-TG and C57BL/6 mice, then
analyzed on a BD FACS Aria III flow cytometer for forward scatter, a measure of cell
size A) representative plot of thymocytes in female mice B) representative plot of
thymocytes in male mice; Black histogram represents C57BL/6 mice and red histogram
represents Notch1ICN-TG mice. Figure originally included as supplementary for Chapter 5
publication.
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Analysis of thymocyte sub-populations revealed effects dependent on
either Notch1ICN-TG, TCDD activation of the AHR, or on the combination of
Notch1ICN-TG and TCDD activation of the AHR. Specifically, we found that in both
C57BL/6 and Notch1ICN-TG mice, TCDD-activation of the AHR led to a significant
decrease in the absolute number of the most immature population of thymocytes
identified by the absence of both CD4 and CD8 (Fig 22C). The largest population
of thymocytes by cell number, the CD4+CD8+, is reduced in number by more
than 10 fold in the C57BL/6 mice after exposure to TCDD as previously reported
(Fig 22D; p≤0.001; Laiosa et al., 2003, 2002). Moreover, CD4+CD8+ thymocyte
numbers in Notch1ICN-TG are also reduced by approximately 10 fold (p≤0.05),
however, the number of CD4+CD8+ thymocytes in the vehicle-exposed
Notch1ICN-TG is 10 fold lower than vehicle-exposed C57BL/6, suggesting that the
intracellular Notch1 transgene alters the basal thymocyte cell number. In
comparison to the reduction observed in CD4+CD8+ thymocytes, the production
of CD4+ and CD8+ progeny that result from positive selection are differentially
sensitive to the combined effects of Notch1ICN-TG and the TCDD-activated AHR.
Specifically, while the number of CD4 lineage thymocytes is significantly reduced
by exposure to TCDD in both C57BL/6 and Notch1ICN-TG mice (Fig 22E), CD8+
cells are present in equal number in the vehicle- and TCDD-exposed Notch1ICNTG

mice (Fig 22F). Given the differences in thymocyte cell number between

C57BL/6 and Notch1ICN-TG mice, we used a ratio of single positive CD4+ or CD8+
to CD4+CD8+ as a way to normalize the efficiency of thymocyte conversion.
Typically, 95-99% of CD4+CD8+ thymocytes fail selection, which is reflected by
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ratios of less than 0.2 in the C57BL/6 mice. In comparison, the thymocyte
conversion efficiency in Notch1ICN-TG mice is 3 to 5 fold higher in the CD4 and
CD8 lineages, respectively. Moreover, 30µg/kg TCDD produces an excess of
CD8 cells compared to DP cells thus yielding a ratio of CD8+ to CD4+CD8+ cells
that is greater than one, indicating an increase in CD8 conversion efficiency in
Notch1ICN-TG mice (Fig 22H; p≤0.05). These results suggest a potential additive
interaction between the thymocyte-restricted constitutively active intracellular
Notch1 and the ligand-activated AHR during thymocyte development.
Developmental Exposure to TCDD Does Not Affect Survival Into Adulthood of
Notch1ICN-TG transgenic mice.
Based on our recent findings linking developmental TCDD exposure to
attenuation of Notch1-dependent lymphocyte differentiation (Ahrenhoerster et al.,
2014), and previous work demonstrating that developmental AHR activation
adversely impacts later life immunity (Hogaboam et al., 2007), we hypothesized
that developmental AHR activation by TCDD reprograms hematopoietic
progenitor cells such that susceptibility to later-life genetically-based T-cell
leukemia-like disease is increased. We tested this hypothesis in T-cell thymoma
prone NotchICN-TG mice by initially following the survival of Notch1ICN-TG mice
exposed to either vehicle or 3µg/kg of TCDD throughout gestation (GD 0.5, 7.5,
14.5 and PPD 2.5). The in utero and lactationally-exposed pups were followed
until death or 12 weeks of age. Although approximately 40% of Notch1ICN-TG
mice died during the experiment, there was no significant difference in overall
survival between TCDD- or vehicle-exposed Notch1ICN-TG mice (Fig. 24).

115

Figure 24: Survival of C57BL/6 or Notch1ICN-TG mice following developmental
exposure to 3µg/kg TCDD or vehicle control. Pregnant C57BL/6 dams (paired with
either C57BL/6 or Notch1ICN-TG males) were exposed to 3µg/kg TCDD or vehicle control
throughout gestation (GD0.5, GD7.5, GD14.5, PPD2.5). Resulting offspring were
followed through twelve weeks of age to determine age of death. C57BL/6 mice are
represented with a black line (vehicle and TCDD; n=35). Notch1ICN-TG mice are
represented with a red line (vehicle; n=72) or blue line (TCDD; n=63). Survival fractions
were calculated using Kaplan-Meier analysis, and survival curves were compared using
the log-rank (Mantel-Cox) test (C57BL/6 p=1.00; Notch1ICN-TG p=0.62).

Developmental TCDD exposure in Notch1ICN-TG mice skews blood B cell to T cell
and CD4 to CD8 ratios in adult mice.
It is well established that Notch1ICN-TG mice have an altered ratio of CD4+
to CD8+ T cells compared to non-transgenic mice (Fowlkes and Robey, 2002;
Robey et al., 1996), but the combined effect of developmental exposure to AHR
agonists such as TCDD had not been examined in these mice. In order to more
specifically quantify differences in thymoma initiation and progression following
developmental exposure to TCDD in Notch1ICN-TG mice, we collected blood

116
samples each week between 5 and 12 weeks of age, and quantified the
proportions of circulating lymphocytes (Fig. 25A-C). No significant difference was
found between treatments at any time point in either C57BL/6 or Notch1ICN-TG
mice in the percentage of macrophages and granulocytes, as evidenced by
percent of CD11b+ or Gr1+CD11b+ cells, respectively (Fig. 25A, B & G).
Similarly, we found no significant difference between vehicle or TCDD exposure
in the ratio of B cells to T cells or in CD4+ T cells to CD8+ T cells in the C57BL/6
mice (Fig. 25C & H). However, in Notch1ICN-TG mice, we saw a significantly lower
ratio of B cells to T cells following developmental exposure to TCDD (Fig. 25D &
H). Additionally, we saw a significantly lower ratio of CD4+ T cells to CD8+ T
cells in mice developmentally exposed to TCDD (Fig 25F & I). Notably, in
Notch1ICN-TG mice, the ratio of B cells to T cells, and the ratio of CD4+ to CD8+ T
cells in mice developmentally exposed to TCDD decreased almost to the level
found in C57BL/6 mice. These data suggest that developmental exposure to
TCDD provides protection from the alterations caused by a constitutively active
Notch1 in thymocytes.
To determine if the change in the CD4+ to CD8+ ratio following
developmental TCDD exposure could be explained by preferential survival of the
CD8+ cells, we used the TUNEL assay to compare apoptosis in the thymus of 8
week old mice. We found no significant difference in the survival of CD4+ cells,
CD8+ cells, or CD4+CD8+ cells following developmental TCDD exposure in
either gender of mice (Fig. 26).
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Figure 25: Proportion circulating lymphocytes in the blood following
developmental exposure to 3µg/kg TCDD or vehicle control. Pregnant C57BL/6
dams (after pairing with either C57BL/6 or Notch1ICN-TG males) were exposed to 3µg/kg
TCDD or vehicle control throughout gestation (GD0.5, GD7.5, GD14.5, PPD2.5). A-F)
Representative flow cytometry plots from week 8 blood samples, illustrating distribution
and analysis of CD11b and Gr-1 positive cells (A), CD3+ T cells and CD19+B cells (C &
D), and CD8+ and CD4+ T cells, gated on CD3+ (E & F). Frequency of Gr1+CD11b+
blood cells (G), the ratio of B cells to T cells in blood (H), or the ratio of CD4+ T cells to
CD8+ T cells in blood (I) in both C57BL/6 mice (graphs on left) and Notch1ICN-TG (graphs
on right). Vehicle treated mice are represented by a white bar and mice treated with
TCDD are represented by a filled bar in G-I. Bars graph mean with SE. A single *
indicates p≤0.05; ** indicates p≤0.01; *** indicates p≤0.001.
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Figure 26. Percentage of apoptotic thymocytes in Notch1ICN-TG mice are not
significantly different following developmental exposure to vehicle control or
3µg/kg TCDD. Notch1ICN-TG mice were exposed to 3µg/kg TCDD or vehicle control on
GD 0.5, 7.5, 14.5 and PPD 2.5. Thymuses were harvested from 8 week old mice and a
TUNEL assay was used to determine percentage of cells undergoing apoptosis. A)
CD4+ thymocytes; B) CD8+ thymocytes; C) Double positive (CD4+CD8+) thymocytes.
Figure originally included as supplementary for Chapter 5 publication.

Peripheral thymomas in Notch1ICN-TG mice following developmental TCDD
exposure exhibit altered B cell:T cell ratios and differential expression of CD5.
The spleen is almost always involved in murine leukemia and neoplasms
(Yang et al., 2013) thus we further examined splenic tissue to search for
metastatic thymomas. We observed alterations in the B cell to T cell ratio in
spleens (Fig. 28), similar to that found in blood (Fig. 25). Specifically, TCDD-

120
exposed C57BL/6 mice showed a significantly lower B cell to T cell ratio
difference at 8 weeks (Fig. 28A & E; p≤0.01). Notch1ICN-TG mice also showed a
significant decrease in the ratio of B cells to T cells following developmental
exposure at both 8 weeks (p≤0.001) and 12 weeks (p≤0.05) of age (Fig. 28B, D
& E). Although both week 8 C57BL/6 and weeks 8 and 12 Notch1ICN-TG mice
showed significant differences in B cell to T cell ratios, the magnitude of
difference in Notch1ICN-TG mice was much greater. Whereas in C57BL/6 mice,
the ratio decreased by 30 percent (2.7 in vehicle-exposed to 1.9 in TCDDexposed), in Notch1ICN-TG mice, the ratio decreased over 50 percent at week 8
(23.6 in vehicle-exposed to 11.4 in TCDD-exposed) and over 60 percent at week
12 (9.7 in vehicle-exposed to 3.3 in TCDD-exposed).
We further measured CD5 expression in CD4+ and CD8+ splenic T cells
as a proxy for T cell activation (Fig. 28F). We found the mean fluorescence
intensity (MFI), an indication of the density of CD5 on the cell surface, was nearly
two-fold lower in the CD8+ population. However, in both the CD4+ and CD8+
populations, cells from mice developmentally exposed to vehicle control had
greatly decreased MFI. Additionally, in both cases, MFI in cells isolated from
spleens of Notch1ICN-TG mice developmentally exposed to TCDD returned to near
the MFI levels seen in C57BL/6 mice. These data show that Notch1ICN-TG mice
developmentally exposed to TCDD approach a B cell to T cell ratio and a CD5
MFI similar to the wild type C57BL/6 vehicle-exposed mice.
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Figure 27: CD4 and CD8 cell proportions in thymus are not significantly different
following developmental exposure to 3µg/kg TCDD or vehicle control. Pregnant
C57BL/6 dams (paired with either C57BL/6 or Notch1ICN-TG males) were exposed to
3µg/kg TCDD or vehicle control throughout gestation (GD0.5, GD7.5, GD14.5, PPD2.5).
A) Representative flow cytometry plots from week 8 thymus samples; B) Ratios of B
cells to T cells at 8 weeks and 12 weeks, with C57BL/6 mice on the left and Notch1ICN-TG
mice on the right; C) Frequency of viable cells (defined by absence of sytox blue stain) in
double positive (CD4+CD8+) quadrant of flow cytometry plots. Vehicle treated mice are
represented by a white bar and mice treated with TCDD are represented by a filled bar
in B-C. Bars graph mean with SE. (n=3 C57BL/6 vehicle; n=3 C57BL/6 TCDD; n=8
Notch1ICN-TG vehicle; n=7 Notch1ICN-TG TCDD at week 8; n=4 C57BL/6 vehicle; n=5
C57BL/6 TCDD; n=6 Notch1ICN-TG vehicle; n=8 Notch1ICN-TG TCDD at week 12);
C57BL/6 mice are pictured on the left. Notch1ICN-TG mice are pictured on the right.
Figure originally included as supplementary for Chapter 5 publication.
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Figure 28: Cell proportions in spleen are altered following developmental
exposure to 3µg/kg TCDD or vehicle control. Pregnant C57BL/6 dams (paired with
either C57BL/6 or Notch1ICN-TG males) were exposed to 3µg/kg TCDD or vehicle control
throughout gestation (GD0.5, GD7.5, GD14.5, PPD2.5). A and C) Representative flow
cytometry plots delineating B and T cells from weeks 8 and 12 C57BL/6 spleen samples;
B and D) Representative splenic B versus T cell flow cytometry plots from weeks 8
and12 in Notch1ICN-TG; E) Ratios of B cells to T cells at 8 weeks and 12 weeks, with
C57BL/6 mice on the left and Notch1ICN-TG mice on the right; F) Mean fluorescence
intensity of CD5 in T-cells from 6-8 week old mice, within the CD4 population on the left
and the CD8 population on the right; Vehicle treated mice are represented by a white bar
and mice treated with TCDD are represented by a filled bar in D-E. Bars graph mean
with SE. A single * indicates p≤0.05; ** indicates p≤0.01; *** indicates p≤0.001. (n=3
C57BL/6 vehicle; n=3 C57BL/6 TCDD; n=8 Notch1ICN-TG vehicle; n=7 Notch1ICN-TG TCDD
at week 8; n=4 C57BL/6 vehicle; n=5 C57BL/6 TCDD; n=6 Notch1ICN-TG vehicle; n=8
Notch1ICN-TG TCDD at week 12).
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Spleen size was significantly smaller in Notch1ICN-TG mice following
developmental TCDD exposure than in vehicle controls.
Upon necropsy, many of the vehicle control Notch1ICN-TG mice had
enlarged spleens--a sign of leukemic infiltration (Zhang et al., 2013) and this
enlargement was much more common and severe in vehicle mice than in
developmentally TCDD-exposed Notch1ICN-TG mice. Specifically, we found a
statistically significant difference in spleen weight, size and length between the
exposed and control groups (p≤0.01; Fig. 29A-C). Furthermore, we used a
numerical grading system in order to insure that spleens exhibiting severe
splenomegaly did not bias the mean values shown in Fig. 29A-C. As previously
published (Duggan et al., 2012), the grading system categorized spleens into
grades 1-4 based on the following weights: normal (<0.2 g; Grade 1), moderate
enlargement (≥0.2 - <0.5g; Grade 2), severe enlargement (≥0.05 - <1.0g;
Grade 3), or morbid enlargement (≥1.0g; Grade 4). Whereas over 80% of
spleens in the gender-combined TCDD-treated group fell into the “normal spleen”
range, less than half of those in the vehicle group could be categorized as normal
(Fig. 29D). Furthermore, this effect was even more pronounced in the female
Notch1ICN-TG mice. None of the C57BL/6 wild type mice used in this experiment
exhibited any spleen enlargement, supporting presence of metastatic thymomas
as the cause of splenomegaly.
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Figure 29: TCDD-exposed Notch1ICN-TG mice fail to develop Notch1-mediated
splenomegaly. Developmental exposure to TCDD in Notch1ICN-TG mice results in
significantly smaller adult spleen size. Pregnant C57BL/6 dams were paired with
Notch1ICN-TG males and exposed to 3µg/kg TCDD or vehicle control throughout gestation
(GD0.5, GD7.5, GD14.5, PPD2.5). Vehicle treated mice are represented by a white bar
and mice treated with TCDD are represented by a filled bar. Bars graph mean with SE.
A single * indicates p≤0.05; ** indicates p≤0.01; *** indicates p≤0.001. Comparisons of
spleen weight (A), length (B), and width (C) were all made on 8 week old mice; spleen
grading was done across all mice between 8-12 weeks of age at any age of necropsy.
(n= 38 vehicle and 23 TCDD mice in A-C; n=61 vehicle and 52 TCDD mice in D)
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DISCUSSION

In the present study, we demonstrate that developmental exposure to the
environmental contaminant and AHR agonist TCDD during development in
Notch1-dependent thymoma-prone mice reprograms long-term HSCs such that
the adult thymic progeny of these cells have an attenuated response to the
Notch1-dependent CD4 versus CD8 lineage decision. Specifically, the unusually
large CD4:CD8 ratio observed in Notch1ICN-TG mice is restored to nearly C57BL/6
wild-type levels in the Notch1ICN-TG TCDD-exposed offspring. These data are
therefore consistent with the conclusion that developmental AHR activation
provides a means of disease protection to mice possessing a Notch1-mediated
propensity to develop leukemic thymomas.
We have previously shown that developmental exposures to TCDD
reprogram long-term reconstituting HSCs, impacting their ability to complete
lymphocyte lineage commitment (Ahrenhoerster et al., 2014). These studies
extend the impact of AHR-induced HSC reprogramming by demonstrating a longterm attenuated response to Notch1-mediated T-cell differentiation evidenced by
the CD4 to CD8 lineage switch observed in peripheral T-cells from offspring
exposed to TCDD during development. Taken together, these data are
consistent with the conclusion that in a progenitor cell population in the fetus
there are epigenetic or stable changes to the chromatin influenced by AHR
activation that have later-life impacts on gene expression and cellular
differentiation. Notably, the impact of this reprogramming on hematopoietic
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differentiation is not readily apparent in wild type C57BL/6 mice. Rather, for the
later-life alterations to produce a measurable change in cellular function, the
progeny of the long-term progenitor cells need to differentiate and be challenged
by a secondary stressor such as the constitutively active intracellular Notch
transgene in the thymus.
The acute exposure experiment demonstrated an increase in CD8
conversion efficiency following TCDD exposure in both C57Bl/6 and Notch1ICN-TG
adult mice in the thymus, though not in the periphery (data not shown), providing
initial evidence of potential AHR-Notch crosstalk. However, the substantial thymic
atrophy resulting from adult TCDD exposure complicated interpretation of the
mechanism for the increase in CD8+ cell conversion efficiency. Thus the switch
to a developmental exposure model combined with a 10-fold decrease in dose
throughout gestation allowed us to more clearly elucidate the effect that AHR
activation had on Notch signal transduction throughout the lifecourse. Using this
developmental model, any TCDD-induced thymic atrophy that occurred in fetal or
neonatal mice was resolved by adulthood as indicated by similar thymic CD4+
and CD8+ populations as adults. Thus, the long-term developmental studies
identified more sensitive and longer lasting outcomes than the adult exposure
experiments. Specifically, developmental TCDD-exposure affected peripheral Tcell homeostasis demonstrated by a significant change in the efficiency of
generating post-selection CD8+ T cells.
One interpretation of this study could be that early life AHR activation by
TCDD is actually beneficial for Notch-mediated hematopoietic disease. However,
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Notch signaling is crucial for fetal HSC development and proliferation, for T
lineage choice (Bigas and Espinosa, 2012), and for normal T cell development in
both the fetus and adult (Osborne and Minter, 2007; Schmitt and ZúñigaPflücker, 2002). Therefore, impairment of physiological Notch signaling in HSCs
and T cells has the potential to alter normal development and the consequences
of this attenuation could impact a spectrum of hematological-based diseases.
Physiological Notch1-dependent signal transduction is characterized by
engagement of the extracellular portion of Notch with Jagged or Delta-like
ligands on a neighboring cell. This protein-protein engagement results in the
gamma secretase-mediated cleavage of the intracellular Notch1 (ICN) domain.
The ICN translocates into the nucleus and associates with the CBF1/Su(H)/Lag-1
(CSL) transcription factor complex where it acts as a co-activator driving
transcription of a broad array of genes, including those responsible for T cell
lineage commitment. A potential consequence of ICN over-expression in
Notch1ICN-TG mice could be that the transgene stoichiometrically saturates the
CSL binding site in the Notch signaling pathway leading to aberrant gene
regulation attenuating physiological Notch activity (Beres et al., 2006). The
importance of the transgenic ICN saturation of the CSL binding site in our studies
follows the knowledge that physiological Notch1 is an AHR-regulated gene
(Stevens et al., 2009). Though it is not known whether Notch transcription is
directly controlled by the AHR (Kiss and Diefenbach, 2012), our data suggests
that AHR activation during development leads to a change in responsiveness to
ICN-mediated T cell development that persists throughout the life course.
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Despite equivalent survival rates between Notch1ICN-TG mice
developmentally exposed to TCDD or vehicle (p=0.62), the fatality rate in vehicleexposed Notch1ICN-TG mice was higher than the 20% tumor rate previously
reported at 5 months (Beverly and Capobianco, 2003). It is unknown whether the
propensity for thymoma development increased in our sub-strain of Notch1ICN-TG
mice prior to arriving in our vivarium, or was selected for inadvertently from our
original breeder pair. However, this increased spontaneous thymoma rate made
it difficult to form a conclusion about the original hypothesis that developmental
TCDD exposure would increase later-life disease susceptibility. Nevertheless, the
altered T cell ratios in the blood and splenomegaly differences are consistent
with the conclusion that developmental TCDD exposure impacts Notch1dependent disease initiation.
In terms of the splenomegaly, the expected result that tumor-resistant
C57BL/6 mice survived for the duration of the 12-week experiment without
splenomegaly, indicates that the enlarged spleens are unique to the transgenic
strain we used and not due to the developmental TCDD exposure. The
moderate protection against splenomegaly by developmental TCDD is similar to
autoimmune and inflammatory amelioration following AHR activation (Busbee et
al., 2013; Di Meglio et al., 2014; Kerkvliet, 2009). These data raise the intriguing
possibility that AHR modulators could have efficacy as chemopreventatives or
chemotherapeutics in certain types of leukemia, particularly if combined with
existing treatments allowing for the decreasing of current doses. For example,
gamma-secretase inhibitors (GSIs) that block Notch activation are a promising
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recent treatment for T-ALL, however, the negative side-effects include doselimiting diarrhea (Hernandez Tejada et al., 2014; Takebe et al., 2014).
In addition to the CD4 to CD8 ratio changes mediated by developmental
TCDD exposure, we also observed alterations in the CD5 MFI in both CD4+ and
CD8+ splenic T cells. Specifically, CD5 levels, as determined by MFI, were
significantly decreased in vehicle-exposed Notch1ICN-TG mice when compared to
C57BL/6 mice (Fig. 5E). However, following developmental exposure to TCDD,
the MFI of CD5 in both CD4+ and CD8+ T cells is partially restored to C57BL/6
levels. The consequences of the lower CD5 expression is consistent with a
model of higher TCR signal transduction in T cells from Notch1ICN-TG mice
(Germain, 2002), leading to a potential increase in activation-induced cell death
in the periphery. While we were not able to detect any increases in apoptosis in
vivo (supplemental figure 3), we and others have previously reported the difficulty
in measuring apoptosis in vivo due to rapid clearance by macrophages (Laiosa et
al, 2007). Thus we relied on indirect observations, such as splenomegaly to
support the hypothesis of increased activation-induced cell death given that
spleen enlargement is consistent with the removal of dead and dying cells.
Moreover, elevated removal of dead and dying cells as occurs in a number of
hematological disorders, including leukemia and lymphoma, is a hallmark of
disease. Taken together, the developmental TCDD-dependent increase in CD5
expression in T cells from Notch1ICN-TG mice and the reduction in splenomegaly
in TCDD-exposed Notch1ICN-TG mice supports a model of inhibition of T cell
activation later in life.
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While developmental AHR activation offers protection from later-life CD4+
to CD8+ T cell ratio imbalance and splenomegaly caused by constitutively-active
ICN, the increase in CD8+ T cells that restores the ratio may not be beneficial in
a more physiological model. Specifically, a decrease in the ratio of CD4+ T cells
to CD8+ T cells in blood has been linked to poorer disease outcomes following
diagnosis and treatment in several immunological diseases, including childhood
leukemia (Lustfeld et al., 2014), hepatitis (Ikeda et al., 2012), and HIV (SerranoVillar et al., 2014). We found that Notch1ICN-TG mice developmentally exposed to
TCDD showed a persistently lower CD4+ to CD8+ ratio in peripheral blood,
suggesting a less favorable response to disease treatment.
In summary, our results indicate that prenatal exposure to the
environmental toxicant and AHR agonist TCDD reprograms HSCs and
significantly changing the course of disease in a Notch1-induced murine
thymoma model, as measured by ratios of B cells to T cells, and CD4+ T cells to
CD8+ T cells. Future research on epigenetic changes influenced by exogenous
stimulation of the AHR during development may provide insight into the spectrum
of secondary exposures vulnerable populations are burdened with that increase
their propensity for later-life hematological and other immune deficiencies.
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CHAPTER 6

CONCLUSIONS AND FUTURE DIRECTIONS
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It has long been known that TCDD is a ubiquitous environmental
contaminant and carcinogen linked to disease in multiple systems. TCDD and
related contaminants exert their toxicity through the AHR, a transcription factor
which contributes to regulation of hematopoiesis, among its many functions.
Hematopoiesis, the process by which all blood and immune cells are
formed from HSCs, is a delicate balance between self-renewal and differentiation
of HSCs. Given that HSCs are formed in utero, any alteration during gestation
can have long-term effects on health. Development depends on numerous
factors present (or absent) in the intrauterine environment, and there is growing
knowledge that exposures in utero and soon after birth may have persistent,
detrimental effects on health and disease which may not manifest until later in life
(Fig. 30).
In the research described here, we have shown that exposure to an
environmentally-relevant level of TCDD in utero has effects on the developing
immune system. In mice, the HSCs formed following developmental exposure to
TCDD have a greatly diminished capacity to differentiate into T and B effector
cells. Furthermore, we have shown that developmental TCDD exposure exerts
this effect through the AHR in the fetus.
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Figure 30. Exposure to TCDD in utero potentially affects offspring at particularly
sensitive periods of development. This model illustrates the possible impact of
developmental exposure to AHR-activating environmental contaminants, such as TCDD.
TCDD exposure in the pregnant mother activates the AHR in the fetus, leading to a
reprogramming of HSCs which we have shown attenuates the number of mature B cells,
number of mature T cells, and ratio of CD4+ to CD8+ T cells. As the exposed fetus
matures, at particularly sensitive timepoints such as childhood, puberty, during the
reproductive years, and into older adulthood, the immune system formed from
reprogrammed HSCs may result in an increase in the incidence of hematological
diseases including, but not limited to, autoimmunity, immunosuppression, and cancer.

While determining HSC differentiation potential, an interesting observation
was made: although the ability of the HSCs isolated from exposed mice to
differentiate into lymphocytes was significantly decreased, the number of HSCs
isolated per fetus was increased. Interestingly, both alterations were
approximately two and a half-fold, thus potentially canceling out the effect of
either alone. Dysfunction in cell-cycle regulation should be explored to provide a
clearer picture of the true long-term consequence of developmental exposures by
determining the net quantity of functional effector cells produced.
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Throughout this work, we have used the terms “LSK” and “HSC”
somewhat interchangeably, but they are not technically the same. The cell
surface markers that we used to identify HSCs (as LSKs) resulted in a
heterogeneous mixture of ST- and LT-HSCs, potentially at different stages of
lineage commitment when isolated. Additional cell surface markers, including the
SLAM family (CD48, CD150, CD229, CD244) are known to identify HSCs earlier
in the hierarchy of stem cell-ness and therefore with greater pluripotency (Oguro
et al., 2013). Determining the differentiation potential of LT-HSCs isolated from
fetal livers and comparing to the LSK potentials would help pinpoint the level at
which TCDD-induced HSC re-programming is occurring. Impact on the myeloid
lineage could also be examined to more closely focus the level of HSC hierarchy
at which re-programming appears.
Complete understanding of fetal HSC reprograming must include all sites
of hematopoiesis as well as all maturation states. The yolk sac and AGM are the
site of hematopoiesis before the fetal liver is, and the placenta has also been
suggested as a potential embryonic site of hematopoiesis (Golub and Cumano,
2013). Testing the differentiation potential of HSCs isolated from these alternate
embryonic sites of hematopoiesis, in conjunction with gene expression data,
would expand our knowledge of the mechanism by which HSCs are
reprogrammed during development.
As a follow-up to our experiments showing decreased differentiation
potential of HSCs following developmental AHR activation, we also have shown
that, in a mouse model genetically prone to thymoma, environmental exposure to
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TCDD radically changes the progression of disease as measured by CD4+ and
CD8+ T lymphocyte levels in the blood and spleen. Individual genetic variation in
addition to epigenetic programming can interact with effects caused by
environmental exposures during development. Polymorphisms or epigenetic
reprogramming act in conjunction with developmental AHR activation and
maternal health to produce the variability seen in disease development.
Forming a functional immune system requires integration of self renewal,
proliferation, differentiation, and activation of HSCs. The limiting dilution
experiments that we used only determined lymphocyte differentiation potential of
the HSCs isolated from developmentally-exposed mice. Although it was not
determined that the decreased differentiation potential has a functional effect, we
would expect that it would. While we observed changes in the course of disease
following developmental exposure in Notch transgenic mice, we saw no
significant impact in the wild type mice. However, functionality of the
lymphocytes that develop from HSCs developmentally exposed to TCDD could
be tested in culture or after isolation from adult mice. Comparing cytokine
baseline levels or levels after an immune response, or measuring changes in
gene expression in either case may provide support for true functional impact.
Though we only determined HSC differentiation potential, these findings
still suggest considerable potential consequences on lifelong immunity. Because
the adult immune system develops from HSCs, we would expect that
developmental exposure also affects such immunological health outcomes as
development of cancer or autoimmune diseases. Epidemiologically, rates of
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immune diseases have risen in the last forty to fifty years, which coincides with
industrialization, especially in developing countries. Others have shown that mice
developmentally exposed to TCDD show a weakened immune response to
influenza challenge (B A Vorderstrasse et al., 2004), which lends support to there
being long-term consequences following early alterations in lymphocyte
differentiation potential.
Our research uses TCDD as an AHR agonist, but many other
environmental contaminants, including PCBs, PAHs, and dibenzofurans, are also
AHR ligands. Additionally, many of these substances exist environmentally as
mixtures. Though non-TCDD ligands are more readily metabolized and the
resulting AHR activation is not as persistent, the possibility exists that
developmental exposure to a combination of AHR ligands may cause similar or
altered effects on T cell development or function. An important next step would
be to examine consequences of developmental exposure to a mixture of AHR
ligands.
In addition to exploring additional AHR ligands, it is important to
investigate the impact of developmental TCDD exposure on additional body
systems. Because the AHR is involved in a large number of developmental
pathways, we would expect that gestational exposure to an AHR agonist would
impact not only the hematopoietic system, but other systems as well. Exposure
to an AHR agonist such as TCDD in utero might also cause long-term impact on
the nervous system. In fact, migration of one type of stem cell, neural crest cells,
has been shown to be altered by cigarette smoke acting through the AHR (Sanbe

139
et al., 2009). Additionally, neurons derived from umbilical cord blood stem cells
express the highest levels of AHR and related genes early in development (A. K.
Singh et al., 2013) and embryonic stem cells express AHR, which drives their
differentiation into cardiomyocytes (Wang et al., 2013). The potential for AHRrelated effects following a developmental exposure are extensive and provide
opportunities to expand the findings reported here for the immune system.
Although we controlled for multiple variables, one of the variables that we
did not take into account in this research was the gender effect. Research has,
by convention, more often used male organisms in research studies (Clayton and
Collins, 2014), and we initially followed this convention with the adult mice used.
However, TCDD has endocrine disruption potential, and therefore could have
potentially affected results by gender. Results might be biased in either direction,
as, for example, developmental exposure to TCDD has been shown to feminize
male rats (Ikeda et al., 2005), and to alter expression of more genes in ovaries
than in testes (Magre et al., 2012). We did not genotype fetuses when harvesting
HSCs from GD 14.5 livers, so each experiment contains HSCs from a mix of
male and female. Future research might determine that the differences we found
are more extreme when categorized by gender.
Another variable which might benefit from tighter control is timing, or more
specifically, circadian rhythm. Though our samples were all harvested within a
two hour window, even within that window circadian differences might emerge.
For timed pregnancies, mating may have occurred at any time within a 15 hour
time period, and implantation might have varied as well. Finding a means to more
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accurately time pregnancies, and keeping HSC harvest especially within a small
timeframe might increase the strength of differences seen.
Finally, we observed the greatest inconsistencies in results when working
with AHR transgenic mice. After initial testing to determine response similarity
between AHR+/+ (WT) and AHR+/- (HZ) mice, we eliminated WT mice from our
experiments. Although HZ mice, by virtue of having an AHR allele, should
respond to AHR activation in a manner similar to WT mice, there is a possibility
that unknown factors may be present within the heterozygous population.
Assaying all three genotypes—WT, HZ and KO—might illuminate any subtle
variations between the genotypes.
In conclusion, this research provides evidence for the developmental
origin of health and disease as it pertains to the immune system. We have shown
that developmental exposure to the ubiquitous environmental contaminant TCDD
causes a reprogramming of HSCs such that they are two and a half fold less
likely to differentiate into mature, committed lymphocytes. We have shown that
this effect is mediated through the AHR in fetuses, as fetal mice lacking an AHR
were not affected by the developmental TCDD exposure. Finally, we have
demonstrated that developmental exposure to TCDD, in crosstalk with Notch1
overexpressed in a transgenic mouse, alters the progression of a T cell specific
disease, manifested by development of thymomas. Taken together, they provide
support for the life-long impact of an early life exposure, and offer a potential
explanation for the increasing rates of immune disease over the last fifty years.
This research illustrates the importance of using scientific evidence to drive
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public health practices such as prenatal supplementation and newborn
screening, as well as public health policy such as environmental regulations.
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